Caffeine: study protocols
872 study groups say how much Caffeine participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
1,641 products in our catalogue print how much Caffeine a serving holds.
Most common: 100 mg to 250 mg, 41% of 1,641 products.
| Dose per serving | Products |
|---|---|
| 10 mg or less | 54 |
| 10 mg to 25 mg | 85 |
| 25 mg to 50 mg | 236 |
| 50 mg to 100 mg | 394 |
| 100 mg to 250 mg | 679 |
| 250 mg to 500 mg | 179 |
| over 500 mg | 14 |
Dose per serving from research
485 study groups in 306 studies say how much Caffeine participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mg to 250 mg, 40% of 485 study groups.
| Daily dose | Study groups |
|---|---|
| 25 mg or less | 11 |
| 25 mg to 50 mg | 23 |
| 50 mg to 100 mg | 88 |
| 100 mg to 250 mg | 193 |
| 250 mg to 500 mg | 117 |
| 500 mg to 1 g | 48 |
| over 1 g | 5 |
Commonly used together
131 of 872 study groups took Caffeine with something else. Shown: what 3 or more different studies gave. The 10 most common of 20.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| ephedrine | 21 |
| Green Tea Extract | 11 |
| Taurine | 11 |
| Beta-Alanine | 9 |
| Chlorogenic Acid | 9 |
| Vitamin B12 | 9 |
| Epigallocatechin Gallate | 8 |
| Niacin | 8 |
| Creatine | 7 |
| L-Tyrosine | 7 |
872 study groups
| Study | |||
|---|---|---|---|
| Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study 2012 · Paracetamol + caffeine (PCF) · Men and women aged 18–62 with episodic migraine and 2–8 attacks per month; participants consumed at least two cups of coffee daily. | 130 mg | — | 92 |
| Psychopharmacology of theobromine in healthy volunteers 2013 · caffeine 200 mg · Healthy adults aged 18–35, light users of caffeine and other methylxanthines | 200 mg | 1 day | 84 |
| Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls - A randomized placebo-controlled crossover trial 2025 · caffeine session · Adults aged 18 years or older, including patients with panic disorder and healthy controls | 150 mg | 1 day | 82 |
| Caffeinated coffee enhances co-operative behavior in the Mixed Motive Game in healthy volunteers 2009 · caffeinated coffee · Healthy low-caffeine users | 150 mg | 1 day | 77 |
| Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study 2014 · Regadenoson + caffeine 200 mg · Adults aged 18 years or older, male and female, regular caffeine consumers, clinically stable, with a high likelihood of coronary artery disease | 200 mg | 1 day | 70 |
| Efficacy and safety of a fixed-dose combination of ibuprofen and caffeine in the management of moderate to severe dental pain after third molar extraction 2018 · Caffeine · Men and women aged 18–55 with moderate or severe postoperative dental pain after extraction of 3–4 impacted third molars | 100 mg | 1 day | 70 |
| Caffeine and attentional control: improved and impaired performance in healthy older adults and Parkinson's disease according to task demands 2022 · caffeine · Adults aged 55 years and older: healthy older adults and people with Parkinson’s disease | 100 mg | 1 day | 66 |
| Examining the effects of caffeine during an auditory attention task 2024 · caffeinated chewing gum group · Participants completing an auditory attention task; age and sex not reported | 200 mg | 1 day | 61 |
| Evaluation of macular and peripapillary vascular parameter change in healthy subjects after caffeine intake using optical coherence tomography angiography 2022 · caffeine group · Healthy adults; median age 36.5 years, 16 men and 44 women | 200 mg | 1 day | 60 |
| Heart rate variability and cognitive function following a multi-vitamin and mineral supplementation with added guarana (Paullinia cupana) 2014 · caffeine supplement (C) · Healthy adult men and women aged 18–45 years who regularly consumed caffeine | 100 mg | 1 day | 56 |
| Caffeine reduces accuracy in face recognition memory consolidation 2025 · Caffeine group · Healthy habitual caffeine-consuming adults aged 18–40 years | 200 mg | 1 day | 51 |
| Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study 2018 · caffeine group · Healthy Japanese adults aged 22–59 years, men and women, without a stated diagnosed condition | 200 mg | 1 day | 50 |
| Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study 2004 · diclofenac softgel 100 mg plus caffeine 100 mg · people with migraine without aura treating a moderate or severe migraine attack; age and sex not specified | 100 mg | 1 day | 46 |
| Enhanced mood and psychomotor performance by a caffeine-containing energy capsule in fatigued individuals 2008 · CAF · Healthy volunteers (16 male, 19 female) who remained awake from 5 p.m. to 5 a.m.; ages and condition beyond fatigue are not reported. | 200 mg | 1 day | 35 |
| Post-study caffeine administration enhances memory consolidation in humans 2014 · 200 mg caffeine group · Healthy, caffeine-naive adults aged 18–30 | 200 mg | 1 day | 35 |
| Effects of caffeine are more marked on daytime recovery sleep than on nocturnal sleep 2007 · caffeine condition · Moderate caffeine consumers; 17 followed their habitual sleep-wake cycle and slept at night, and 17 were sleep deprived for one night before daytime recovery sleep | 200 mg | 1 day | 34 |
| Caffeine improves left hemisphere processing of positive words 2012 · caffeine group · Healthy adults aged 19–32 years, both sexes, without a reported neurologic or psychiatric disorder; right-handed, normal or corrected-to-normal vision, and usual caffeine consumers | 200 mg | 1 day | 33 |
| The effect of coffee consumption on postoperative pain and bowel motility following cesarean section: a randomized controlled trial 2025 · intervention group · Women undergoing cesarean delivery, receiving postoperative care | 200 mg | 1 day | 29 |
| Effect of coffee consumption on intraocular pressure 2002 · regular coffee · Patients with normotensive glaucoma or ocular hypertension | 180 mg | 1 day | 28 |
| Effects of caffeine on mood and performance: a study of realistic consumption 2002 · single large dose · Adult volunteers; age and sex not specified; no condition stated | 200 mg | 1 day | 24 |
| Challenging sleep in aging: the effects of 200 mg of caffeine during the evening in young and middle-aged moderate caffeine consumers 2006 · caffeine condition · Adults aged 20–30 and 40–60 years, moderate caffeine consumers (one to three cups of coffee per day) | 200 mg | 1 day | 24 |
| Aging and nocturnal driving: better with coffee or a nap? A randomized study 2007 · coffee · Young adults aged 20–25 and middle-aged adults aged 40–50; no condition stated | 200 mg | 1 day | 24 |
| Effects of caffeine or diphenhydramine on visual vigilance 1994 · caffeine · 24 male volunteers, median age 20, without a stated condition | 200 mg | 1 day | 24 |
| Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial 2025 · 100 mg caffeine, 12 hours before bedtime · Healthy males aged 18–40 years with moderate habitual caffeine intake (<300 mg/day) | 100 mg | 3 weeks | 23 |
| Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial 2025 · 100 mg caffeine, 8 hours before bedtime · Healthy males aged 18–40 years with moderate habitual caffeine intake (<300 mg/day) | 100 mg | 3 weeks | 23 |
| Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial 2025 · 100 mg caffeine, 4 hours before bedtime · Healthy males aged 18–40 years with moderate habitual caffeine intake (<300 mg/day) | 100 mg | 3 weeks | 23 |
| Acute effects of theanine, caffeine and theanine-caffeine combination on attention 2017 · caffeine · Healthy male volunteers | 160 mg | 1 day | 20 |
| Regular Caffeine Intake Delays REM Sleep Promotion and Attenuates Sleep Quality in Healthy Men 2021 · withdrawal condition · Men aged 18–35 years who were healthy regular caffeine consumers, with habitual intake of 300–600 mg/day | 150 mg | 9 days | 20 |
| Transcranial direct current stimulation combined with caffeine promotes executive function in healthy females 2025 · tDCS + caffeine group · Healthy females aged 18–35 years with caffeine intake below 150 mg/day or abstinence | 200 mg | 1 day | 20 |
| Transcranial direct current stimulation combined with caffeine promotes executive function in healthy females 2025 · caffeine alone group · Healthy females aged 18–35 years with caffeine intake below 150 mg/day or abstinence | 200 mg | 1 day | 20 |
| Acute enhancement of Romanian deadlift performance after consumption of caffeinated chewing gum 2023 · Caffeinated gum trial (CAF) · Adults, mean age 22.5 years, with regular exercise and strength-training experience; no specified diagnosed condition | 200 mg | 1 day | 19 |
| Caffeine optimizes Zumba training benefits on functional performances in middle-aged women: a randomized trial study 2024 · caffeine + Zumba training group (Ca + ZT) · Women aged 50–60 years who were healthy, inactive, non-habitual caffeine consumers, and had mild fall risk | 100 mg | 12 weeks | 19 |
| Does caffeine modify corticomotor excitability? 2006 · 200 mg caffeine group (Experiment A) · healthy subjects; age and sex not specified | 200 mg | 1 day | 18 |
| Effect of Coffee and Tea Consumption on Adolescent Weight Control: An Interventional Pilot Study 2023 · coffee · Adolescents with obesity; median age 13 years (IQR 11–14) | 160 mg | 26 weeks | 18 |
| Quantitative measurement of the effects of caffeine and propranolol on surgeon hand tremor 1997 · caffeine group · 17 ophthalmic surgeons tested during simulated vitreoretinal microsurgery; age and sex not reported | 200 mg | 1 day | 17 |
| Caffeine counteracts impairments in task-oriented psychomotor performance induced by chlorpheniramine: a double-blind placebo-controlled crossover study 2013 · placebo-200 mg of caffeine · healthy young men | 200 mg | 1 day | 16 |
| Caffeine counteracts impairments in task-oriented psychomotor performance induced by chlorpheniramine: a double-blind placebo-controlled crossover study 2013 · 4 mg of chlorpheniramine-200 mg of caffeine · healthy young men | 200 mg | 1 day | 16 |
| Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine 2021 · CAF (caffeine) · Healthy men aged 21–36 years without current or past medical, neurological, or psychiatric disorders | 200 mg | 1 day | 16 |
| Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults 2022 · caffeine group · Healthy men aged 21–36 years | 200 mg | 1 day | 16 |
| Caffeine antagonism of alcohol-induced driving impairment 2001 · 200 mg caffeine alone · Adults; age and health condition not reported | 200 mg | 1 day | 15 |
| Low and moderate doses of caffeine late in exercise improve performance in trained cyclists 2016 · CAF1 (low dose) · Trained cyclists, mean age 22.5 years; 11 male and 4 female; no condition reported | 100 mg | 1 day | 15 |
| Low and moderate doses of caffeine late in exercise improve performance in trained cyclists 2016 · CAF2 (moderate dose) · Trained cyclists, mean age 22.5 years; 11 male and 4 female; no condition reported | 200 mg | 1 day | 15 |
| Motor improvement in Parkinson's disease patients receiving caffeine adjuvants: A double-blind randomized controlled trial in Indonesia 2024 · caffeine adjuvant group · Adults, mostly over 60 years, with Parkinson's disease receiving stable symptomatic therapy | 100 mg | 3 weeks | 15 |
| The effect of wrist rest, caffeine, and oral timolol on the hand steadiness of ophthalmologists 1993 · caffeine · 14 ophthalmology trainees | 200 mg | 1 day | 14 |
| The effect of wrist rest, caffeine, and oral timolol on the hand steadiness of ophthalmologists 1993 · caffeine and timolol combination · 14 ophthalmology trainees | 200 mg | 1 day | 14 |
| No evidence for latent learning of liking for flavours conditioned by caffeine 2001 · Test group · Moderate caffeine consumers, tested undeprived on days 1–4 and caffeine-deprived on day 5 | 100 mg | 5 days | 13 |
| No evidence for latent learning of liking for flavours conditioned by caffeine 2001 · Undeprived control group · Moderate caffeine consumers tested in an undeprived state | 100 mg | 5 days | 13 |
| No evidence for latent learning of liking for flavours conditioned by caffeine 2001 · Deprived control group receiving caffeine · Moderate caffeine consumers tested in a caffeine-deprived state | 100 mg | 5 days | 13 |
| The acute effect of a caffeine-containing energy drink on mood state, readiness to invest effort, and resistance exercise to failure 2012 · caffeinated energy drink condition · 13 resistance-trained men; age and health condition not reported | 179 mg | 1 day | 13 |
| The effect of repeated coffee mouth rinsing and caffeinated gum consumption on aerobic capacity and explosive power of table tennis players: a randomized, double-blind, placebo-controlled, crossover study 2024 · Caffeinated gum (CG), participants weighing less than 65 kg · Male table tennis players, mean age 21.86 years, without stated disease | 200 mg | 1 day | 13 |
| Low-dose caffeine enhances cognitive processing but not physical performance in fatigued taekwondo athletes: a randomized crossover trial 2025 · caffeine (CAF) trial · male university-level Taekwondo athletes aged 18–25 years | 200 mg | 1 day | 13 |
| The effects of coffee and napping on nighttime highway driving: a randomized trial 2006 · coffee · 12 young men; mean age 21.3 years | 200 mg | 1 day | 12 |
| Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers 2009 · caffeine · healthy male volunteers | 150 mg | 1 day | 12 |
| Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers 2009 · caffeine plus zolpidem · healthy male volunteers | 150 mg | 1 day | 12 |
| Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers 2009 · caffeine plus trazodone · healthy male volunteers | 150 mg | 1 day | 12 |
| Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance 2017 · 200 mg Caffeine · Healthy, recreationally trained college-aged men | 200 mg | 7 days | 12 |
| Subacute Ingestion of Caffeine and Oolong Tea Increases Fat Oxidation without Affecting Energy Expenditure and Sleep Architecture: A Randomized, Placebo-Controlled, Double-Blinded Cross-Over Trial 2020 · Caffeine · Healthy males aged 20–56 years | 104 mg | 2 weeks | 12 |
| Subacute Ingestion of Caffeine and Oolong Tea Increases Fat Oxidation without Affecting Energy Expenditure and Sleep Architecture: A Randomized, Placebo-Controlled, Double-Blinded Cross-Over Trial 2020 · Oolong tea · Healthy males aged 20–56 years | 104 mg | 2 weeks | 12 |
| Caffeine Gum Improves Reaction Time but Reduces Composure Versus Placebo During the Extra-Time Period of Simulated Soccer Match-Play in Male Semiprofessional Players 2024 · caffeinated gum · Male semiprofessional soccer players, mean age 22 ± 3 years | 200 mg | 1 day | 12 |
| Caffeine optimizes Zumba training benefits on functional performances in middle-aged women: a randomized trial study 2024 · caffeine supplementation group (Ca) · Women aged 50–60 years who were healthy, inactive, non-habitual caffeine consumers, and had mild fall risk | 100 mg | 12 weeks | 12 |
| Comparison of changes in energy expenditure and body temperatures after caffeine consumption 1995 · Decaffeinated coffee with added caffeine · Young healthy male volunteers | 200 mg | 1 day | 12 |
| Guarana (Paullinia cupana) but Not Low-Dose Caffeine Improves Cycling Time-Trial Performance Versus Placebo 2024 · caffeine (CAF) · Endurance-trained adults, including cyclists and noncyclists; age and sex not reported | 100 mg | 1 day | 11 |
| Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans 1999 · caffeine · 10 healthy men | 150 mg | 1 day | 10 |
| Effects of Caffeine on Performances of Simulated Match, Wingate Anaerobic Test, and Cognitive Function Test of Elite Taekwondo Athletes in Hong Kong 2022 · caffeine (CAF) trial · Elite Hong Kong national-team taekwondo athletes; men and women, ages 25–29; no stated diagnosed condition | 200 mg | 1 day | 10 |
| Counteracting driver sleepiness: effects of napping, caffeine, and placebo 1996 · caffeine · 10 sleepy subjects; age and sex not reported | 150 mg | 1 day | 10 |
| The effect of caffeine and albuterol on body composition and metabolic rate 2015 · placebo-caffeine 100 mg · Healthy males and females aged 18–50 years with BMI 19–40 kg/m² | 100 mg | 1 day | 8 |
| The effect of caffeine and albuterol on body composition and metabolic rate 2015 · placebo-caffeine 200 mg · Healthy males and females aged 18–50 years with BMI 19–40 kg/m² | 200 mg | 1 day | 8 |
| The effect of caffeine and albuterol on body composition and metabolic rate 2015 · albuterol 2 mg-caffeine 100 mg · Healthy males and females aged 18–50 years with BMI 19–40 kg/m² | 100 mg | 1 day | 8 |
| The effect of caffeine and albuterol on body composition and metabolic rate 2015 · albuterol 2 mg-caffeine 200 mg · Healthy males and females aged 18–50 years with BMI 19–40 kg/m² | 200 mg | 1 day | 8 |
| The effect of caffeine and albuterol on body composition and metabolic rate 2015 · albuterol 4 mg-caffeine 100 mg · Healthy males and females aged 18–50 years with BMI 19–40 kg/m² | 100 mg | 1 day | 8 |
| The effect of caffeine and albuterol on body composition and metabolic rate 2015 · albuterol 4 mg-caffeine 200 mg · Healthy males and females aged 18–50 years with BMI 19–40 kg/m² | 200 mg | 1 day | 8 |
| Enhancing caffeine reinforcement by behavioral requirements following drug ingestion 1994 · caffeine · Adults with caffeine-versus-placebo discrimination histories | 100 mg | 10 days | 8 |
| Discriminative stimulus and subjective effects of theobromine and caffeine in humans 1994 · Caffeine discrimination and subjective-effects condition · Seven volunteers who abstained from methylxanthines; age, sex, and health status not reported | 178 mg | — | 7 |
| A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality 2000 · Tea equivalent to 1 cup (37.5 mg caffeine) · Healthy volunteers; ages and sex not specified | 150 mg | 1 day | — |
| Expression of flavour preferences conditioned by caffeine is dependent on caffeine deprivation state 2000 · Caffeine during conditioning and caffeine at test · Subjects; age, sex, and health status not reported | 100 mg | 5 days | — |
| Expression of flavour preferences conditioned by caffeine is dependent on caffeine deprivation state 2000 · Caffeine during conditioning and placebo at test · Subjects; age, sex, and health status not reported | 100 mg | 4 days | — |
| Expression of flavour preferences conditioned by caffeine is dependent on caffeine deprivation state 2000 · Placebo during conditioning and caffeine at test · Subjects; age, sex, and health status not reported | 100 mg | 1 day | — |
| Single-dose bright light and/or caffeine effect on nocturnal performance 2002 · 1 h Dim Light-Caffeine · 11 subjects in a simulated shift-work schedule; age and sex not reported | 200 mg | 1 day | — |
| Single-dose bright light and/or caffeine effect on nocturnal performance 2002 · 1 h Bright Light-Caffeine · 11 subjects in a simulated shift-work schedule; age and sex not reported | 200 mg | 1 day | — |
| Caffeine deprivation state modulates coffee consumption but not attentional bias for caffeine-related stimuli 2005 · Caffeine preload, experiment 1 · Habitual caffeine users in a between-subjects experiment; age and sex not reported | 100 mg | 1 day | — |
| Caffeine deprivation state modulates coffee consumption but not attentional bias for caffeine-related stimuli 2005 · Caffeine preload, experiment 2 · Habitual caffeine users in a within-subjects experiment; age and sex not reported | 150 mg | 1 day | — |
| Caffeine deprivation state modulates coffee consumption but not attentional bias for caffeine-related stimuli 2005 · Caffeine preload, experiment 3 · Habitual caffeine users in a within-subjects experiment; age and sex not reported | 100 mg | 1 day | — |
| Multiple caffeine doses maintain vigilance during early morning operations 2005 · 50 mg caffeine group · Adults (28 men and 20 women), sleep-deprived during an overnight operation; age and health status not reported | 150 mg | 1 day | — |
| Effects of oral administration of caffeine and D-ribose on mental fatigue 2008 · caffeine · 17 healthy volunteers | 200 mg | 8 days | — |
| Comparing the benefits of caffeine, naps and placebo on verbal, motor and perceptual memory 2008 · Caffeine group · Adults aged 18–39 without neurological, psychological or other chronic illness; low-to-moderate caffeine drinkers | 200 mg | 1 day | — |
| Early effects of caffeinated and decaffeinated coffee on subjective state and gender differences 2008 · Caffeine · Healthy undergraduate volunteers, mean age 22.03 years; men and women; no stated condition | 100 mg | 1 day | — |
| Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain 1991 · ibuprofen 100 mg with caffeine 100 mg · Outpatients with postoperative pain after surgical removal of impacted third molars; age and sex not specified | 100 mg | 1 day | — |
| Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain 1991 · ibuprofen 200 mg with caffeine 100 mg · Outpatients with postoperative pain after surgical removal of impacted third molars; age and sex not specified | 100 mg | 1 day | — |
| Caffeine in hot drinks elicits cephalic phase responses involving cardiac activity 2012 · Decaffeinated coffee with 134 mg caffeine · Women; age and health condition not stated | 134 mg | 1 day | — |
| Caffeine in hot drinks elicits cephalic phase responses involving cardiac activity 2012 · Regular coffee · Women; age and health condition not stated | 130 mg | 1 day | — |
| Effects of caffeine and alcohol on mood and performance changes following consumption of lager 2013 · No alcohol, 62.5 mg caffeine per drink · Young adults aged 18–30 years; male and female; no specific condition stated | 188 mg | 1 day | — |
| Combined caffeine and bright light reduces dangerous driving in sleep-deprived healthy volunteers: a pilot cross-over randomised controlled trial 2013 · C+L+ · Healthy male volunteers aged 20 to 50 years | 200 mg | 1 day | — |
| Combined caffeine and bright light reduces dangerous driving in sleep-deprived healthy volunteers: a pilot cross-over randomised controlled trial 2013 · C+L- · Healthy male volunteers aged 20 to 50 years | 200 mg | 1 day | — |
| Post-study caffeine administration enhances memory consolidation in humans 2014 · 100 mg caffeine group · Healthy, caffeine-naive adults aged 18–30 | 100 mg | 1 day | — |
| Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates 2017 · 120 mg caffeine group · Male inpatients with major depressive disorder taking current antidepressant medication | 120 mg | 4 weeks | — |
| The Acute Effects of Caffeinated Black Coffee on Cognition and Mood in Healthy Young and Older Adults 2018 · regular coffee · Healthy habitual caffeine-consuming adults aged 20–34 or 61–80 years, men and women | 100 mg | 1 day | — |
| Impact of Caffeine Ingestion on the Driving Performance of Anesthesiology Residents After 6 Consecutive Overnight Work Shifts 2020 · Caffeinated energy drink · Anesthesiology resident physicians after 6 consecutive night-float shifts; age and sex not specified | 160 mg | 1 day | — |
| The effects of caffeine on drowsiness in patients with narcolepsy: a double-blind randomized controlled pilot study 2020 · caffeine · people with narcolepsy; age and sex not stated | 200 mg | 7 days | — |
| The Impact of Caffeine Intake on Mental Health Symptoms in Postmenopausal Females with Overactive Bladder Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial 2022 · 200 mg/day caffeine · Postmenopausal females with overactive bladder symptoms; age range not specified | 200 mg | 7 days | — |
| Effects of 12 weeks of caffeine supplementation and Zumba training on postural balance and cognitive performances in middle-aged women 2023 · caffeine-Zumba (CZG) · Middle-aged women | 100 mg | 12 weeks | — |
| Short-Term Dietary Caffeine Intake for Alleviating Symptoms of Burning Mouth Syndrome: A Randomised Controlled Comparison With Alpha-Lipoic Acid 2025 · caffeine group · BMS patients; age and sex not specified | 120 mg | 2 weeks | — |
| Efficacy of caffeine supplementation on fatigue in patients with multiple sclerosis: A randomized double-blind placebo-controlled trial 2026 · caffeine · People with multiple sclerosis and self-reported fatigue | 100 mg | 12 weeks | — |
| Mental effects of caffeine in fatigued and non-fatigued female and male subjects 1995 · Caffeine treatment, experiment 2 · Male and female subjects; age and health status not stated | 200 mg | 1 day | — |
| Mental effects of caffeine in fatigued and non-fatigued female and male subjects 1995 · Caffeine treatment, experiment 3 · Non-sleep-deprived male and female subjects; age and health status not stated | 200 mg | 1 day | — |
| Conditioned flavour preferences reinforced by caffeine consumed after lunch 1996 · Caffeine capsule · Caffeine-consuming adult males and females, including regular postlunch caffeine users and nonusers | 100 mg | 2 weeks | — |
| Ibuprofen compared with ibuprofen plus caffeine after third molar surgery 1996 · ibuprofen 200 mg plus 100 mg of caffeine · Patients undergoing lower third molar removal | 100 mg | 1 day | — |
| Ibuprofen compared with ibuprofen plus caffeine after third molar surgery 1996 · ibuprofen 200 mg plus 200 mg of caffeine · Patients undergoing lower third molar removal | 200 mg | 1 day | — |
| Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man 1998 · caffeine 150 mg alone (daytime study I) · healthy students; age and sex not specified | 150 mg | 1 day | — |
| Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man 1998 · zolpidem plus caffeine 150 mg (daytime study I) · healthy students; age and sex not specified | 150 mg | 1 day | — |
| Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial 2025 · caffeine · Infants born at 29 to 33 weeks' gestation, enrolled at 33 to 35 weeks' postmenstrual age while receiving caffeine and full feeds | 10 mg/kg | — | 416 |
| Caffeine challenge test in panic disorder and depression with panic attacks 2007 · caffeine challenge · Patients with panic disorder, major depression with panic attacks, or major depression without panic attacks, and healthy volunteers | 480 mg | 1 day | 109 |
| Combined intake of caffeine and low-dose glucose to reduce exercise-related hypoglycaemia in individuals with type 1 diabetes on ultra-long-acting insulin degludec: A randomized, controlled, double-blind, cross-over trial 2024 · CAF · Adults with type 1 diabetes using ultra-long-acting insulin degludec | 250 mg | 1 day | 16 |
| High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial 2004 · 20 mg/kg/day caffeine citrate group · Neonates born at less than 30 weeks gestation who were ventilated for more than 48 hours | 20 mg/kg | — | — |
| High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial 2004 · 5 mg/kg/day caffeine citrate group · Neonates born at less than 30 weeks gestation who were ventilated for more than 48 hours | 5 mg/kg | — | — |
| Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study 2006 · AAC (acetaminophen, aspirin, and caffeine combination) · People with acute migraine; age and sex not specified | 65 mg | 1 day | 669 |
| Efficacy and safety of a fixed-dose combination of ibuprofen and caffeine in the management of moderate to severe dental pain after third molar extraction 2018 · Ibuprofen/caffeine · Men and women aged 18–55 with moderate or severe postoperative dental pain after extraction of 3–4 impacted third molars | 100 mg | 5 days | 213 |
| Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study 2014 · Regadenoson + caffeine 400 mg · Adults aged 18 years or older, male and female, regular caffeine consumers, clinically stable, with a high likelihood of coronary artery disease | 400 mg | 1 day | 71 |
| Caffeine as an analgesic adjuvant. A double-blind study comparing aspirin with caffeine to aspirin and placebo in patients with sore throat 1991 · 800 mg of aspirin with 64 mg of caffeine · Patients with acute sore throat due to tonsillopharyngitis; age and sex not reported | 64 mg | 1 day | 70 |
| Situational insomnia: consistency, predictors, and outcomes 2003 · 400 mg caffeine condition · 50 adult normal sleepers; results describe a subgroup with situational insomnia based on poor sleep efficiency on the adaptation night | 400 mg | 1 day | 50 |
| Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting 2004 · caffeine (CAF) · male smokers | 356 mg | 1 day | 50 |
| In-car nocturnal blue light exposure improves motorway driving: a randomized controlled trial 2012 · coffee · Healthy male volunteers aged 20–25 or 40–50 years | 400 mg | 1 day | 48 |
| Involvement of Cardiorespiratory Capacity on the Acute Effects of Caffeine on Autonomic Recovery 2019 · caffeine protocol · Healthy young adult men, mean age 23.59 ± 3.45 years, divided into higher- and lower-cardiorespiratory-capacity groups; without the excluded cardiopulmonary or other specified disorders | 300 mg | 1 day | 40 |
| Trait Energy and Fatigue Modify the Effects of Caffeine on Mood, Cognitive and Fine-Motor Task Performance: A Post-Hoc Study 2021 · caffeine condition · Adults aged 18–45 without the specified chronic health conditions; 17 women and 13 men completed the study | 98 mg | 1 day | 30 |
| Does caffeine enhance bowel recovery after elective colorectal resection? A prospective double-blinded randomized clinical trial 2021 · caffeine group · Adults undergoing elective laparoscopic colectomy | 300 mg | — | 30 |
| Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial 2023 · caffeine · Healthy Royal Netherlands Air Force employees aged 18–60 years; fit to fly, without a stated diagnosed condition | 300 mg | 1 day | 30 |
| Daily Caffeine Intake and the Effect of Caffeine on Pilots' Performance After Extended Wakefulness 2023 · caffeine condition · Aeromedically fit subjects, including military aviation personnel, studied after extended wakefulness | 300 mg | 1 day | 30 |
| A moderate dosage of coffee causes acute retinal capillary perfusion decrease in healthy young individuals 2022 · coffee · Healthy university students aged 18–30 years; no ocular, systemic, or neurologic disease | 72 mg | 1 day | 27 |
| Effects of caffeine on mood and performance: a study of realistic consumption 2002 · multiple small doses · Adult volunteers; age and sex not specified; no condition stated | 260 mg | 1 day | 24 |
| Caffeine improves physical and cognitive performance during exhaustive exercise 2008 · CAF · Well-trained cyclists | 300 mg | 1 day | 24 |
| Attentional and working memory performance following alcohol and energy drink: A randomised, double-blind, placebo-controlled, factorial design laboratory study 2019 · ED · Healthy adults aged 18–40, regular caffeine and alcohol consumers | 80 mg | 1 day | 24 |
| The effects of TeaCrine® and caffeine on endurance and cognitive performance during a simulated match in high-level soccer players 2019 · Caffeine (Caf) · Male and female Division I and professional soccer players, highly trained and participating in soccer-related activities at least 5 days per week | 275 mg | 1 day | 24 |
| Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial 2025 · 400 mg caffeine, 12 hours before bedtime · Healthy males aged 18–40 years with moderate habitual caffeine intake (<300 mg/day) | 400 mg | 3 weeks | 23 |
| Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial 2025 · 400 mg caffeine, 8 hours before bedtime · Healthy males aged 18–40 years with moderate habitual caffeine intake (<300 mg/day) | 400 mg | 3 weeks | 23 |
| Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial 2025 · 400 mg caffeine, 4 hours before bedtime · Healthy males aged 18–40 years with moderate habitual caffeine intake (<300 mg/day) | 400 mg | 3 weeks | 23 |
| Prophylactic caffeine mitigates systemic hypercapnia and headache during graded carbon dioxide exposure in healthy males and females: a randomized crossover trial 2025 · caffeine · Healthy males and females; age range not reported | 400 mg | 1 day | 23 |
| Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity 2006 · caffeine condition · young men, including 12 subjectively caffeine-sensitive and 10 caffeine-insensitive men | 400 mg | 1 day | 22 |
| Measuring caffeine-induced changes in middle cerebral artery blood velocity using transcranial Doppler in patients recovering from ischaemic stroke 2002 · caffeine · Patients recovering from ischaemic stroke in the middle cerebral artery territory; mean age 70; 18 men and 2 women | 250 mg | 1 day | 20 |
| Cerebral blood flow and behavioural effects of caffeine in habitual and non-habitual consumers of caffeine: a near infrared spectroscopy study 2011 · caffeine · healthy young habitual and non-habitual consumers of caffeine | 75 mg | 1 day | 20 |
| Acute effects of theanine, caffeine and theanine-caffeine combination on attention 2017 · theanine-caffeine combination · Healthy male volunteers | 160 mg | 1 day | 20 |
| The effects of caffeine and d-amphetamine on spatial span task in healthy participants 2023 · Caffeine · Healthy adults aged over 17 and under 60; experiment 2 participants had a mean age of 22.2 years | 400 mg | 1 day | 20 |
| Caffeine Combined with Excitatory Neuromodulation Based on Transcranial Direct Current Stimulation (tDCS) Enhances Performance in a Time-Trial CrossFit(®) Workout: A Randomized, Placebo-Controlled, Double-Blind Study 2025 · 400 mg CAF + a-tDCS · Male competitive CrossFit athletes, physically active and classified as advanced or highly advanced, with more than five years of training experience | 400 mg | 1 day | 20 |
| Caffeine Combined with Excitatory Neuromodulation Based on Transcranial Direct Current Stimulation (tDCS) Enhances Performance in a Time-Trial CrossFit(®) Workout: A Randomized, Placebo-Controlled, Double-Blind Study 2025 · 400 mg CAF + Sham-tDCS · Male competitive CrossFit athletes, physically active and classified as advanced or highly advanced, with more than five years of training experience | 400 mg | 1 day | 20 |
| A caffeine and theacrine combination improves cognitive performance in tactical personnel under physically fatiguing conditions 2025 · CAF (caffeine alone) · Physically active adults aged 21.5 ± 3.8 years, including ROTC cadets or midshipmen and military or law-enforcement officers; no stated diagnosed condition | 300 mg | 1 day | 20 |
| A caffeine and theacrine combination improves cognitive performance in tactical personnel under physically fatiguing conditions 2025 · CTC (caffeine plus theacrine) · Physically active adults aged 21.5 ± 3.8 years, including ROTC cadets or midshipmen and military or law-enforcement officers; no stated diagnosed condition | 150 mg | 1 day | 20 |
| Effects of coffee and caffeine anhydrous on strength and sprint performance 2016 · caffeine anhydrous (CAF) · Resistance-trained males aged 20.1 ± 2.1 years; participants weighed 60–100 kg and had no stated diagnosed condition | 300 mg | 1 day | 18 |
| Randomized Controlled Trial of High-Volume Energy Drink Versus Caffeine Consumption on ECG and Hemodynamic Parameters 2017 · Caffeine control · Healthy adults aged 18–40 years, men and women, with no stated diagnosed condition | 320 mg | 1 day | 18 |
| Wide awake at bedtime? Effects of caffeine on sleep and circadian timing in male adolescents - A randomized crossover trial 2021 · caffeine · Male adolescents aged 14–17 years | 80 mg | 1 day | 18 |
| Caffeine gum improves 5 km running performance in recreational runners completing parkrun events 2024 · Caffeine gum (crossover phase) · Recreationally trained runners aged 18–65, free of known disease and able to run 5 km in under 25 minutes | 300 mg | 1 day | 18 |
| The effect of repeated coffee mouth rinsing and caffeinated gum consumption on aerobic capacity and explosive power of table tennis players: a randomized, double-blind, placebo-controlled, crossover study 2024 · Coffee mouth rinsing (CMR) · Male table tennis players, mean age 21.86 years, without stated disease | 300 mg | 1 day | 18 |
| Effect of coffee on endothelial function in healthy subjects: the role of caffeine 2005 · Caffeinated coffee session · Healthy young adults, mean age 28.9 years, nine men; regular non-heavy coffee drinkers | 80 mg | 1 day | 17 |
| Caffeinated Gel Ingestion Enhances Jump Performance, Muscle Strength, and Power in Trained Men 2019 · caffeinated gel · Resistance-trained men aged 18–45 years without current muscular injuries or other physical limitations | 300 mg | 1 day | 17 |
| Caffeinated Gel Ingestion Enhances Jump Performance, Muscle Strength, and Power in Trained Men 2019 · caffeinated gel · Resistance-trained men aged 18–45 years without current muscular injuries or other physical limitations | 300 mg | 1 day | 17 |
| Effects of Mixing Energy Drinks With Alcohol on Driving-Related Skills 2022 · Red Bull + placebo alcohol · Healthy men aged 19–29 years who regularly consumed alcohol and methylxanthine-containing drinks; BMI 19–27 kg/m² | 240 mg | 1 day | 16 |
| Caffeine antagonism of alcohol-induced driving impairment 2001 · 400 mg caffeine alone · Adults; age and health condition not reported | 400 mg | 1 day | 15 |
| Effects of caffeine on visual evoked potential (P300) and neuromotor performance 2004 · caffeine · Healthy volunteers, women and men, mean age 26 ± 5 years | 400 mg | 1 day | 15 |
| Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate 2018 · caffeine group · Patients with more than intermediate coronary stenosis undergoing fractional flow reserve measurement; age and sex not reported | 222 mg | 1 day | 15 |
| Improvement of 2000-m rowing performance with caffeinated carbohydrate-gel ingestion 2015 · caffeinated carbohydrate gel (CC) · rowers; age, sex, and health condition not specified | 100 mg | 1 day | 13 |
| Central and peripheral effects of sustained caffeine use: tolerance is incomplete 2002 · C-replete · 12 healthy volunteers | 400 mg | 7 days | 12 |
| Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48 h of total sleep deprivation 2019 · 200 mg caffeine condition · Healthy adults aged 18–39 years, six women and six men, without a stated diagnosed condition | 400 mg | 2 days | 12 |
| Cardiac autonomic activity during sleep deprivation with and without caffeine administration 2019 · 200 mg caffeine · Healthy adults aged 19–39 years, women and men | 400 mg | 2 days | 12 |
| Effects of Caffeine Intake on Cardiopulmonary Variables and QT Interval after a Moderate-Intensity Aerobic Exercise in Healthy Adults: A Randomized Controlled Trial 2022 · caffeine beverage intake before exercise · Healthy men aged 19–25 years | 237 mg | 1 day | 12 |
| Effects of Caffeine Intake on Cardiopulmonary Variables and QT Interval after a Moderate-Intensity Aerobic Exercise in Healthy Adults: A Randomized Controlled Trial 2022 · caffeine beverage intake immediately after exercise · Healthy men aged 19–25 years | 237 mg | 1 day | 12 |
| The Effect of Creatine Nitrate and Caffeine Individually or Combined on Exercise Performance and Cognitive Function: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial 2024 · caffeine (CAF) · resistance-trained males aged 18–40 without the listed metabolic or cardiovascular conditions | 400 mg | 7 days | 12 |
| Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans 1997 · 250 mg of caffeine · 12 healthy volunteers; age range and sex not reported | 250 mg | 1 day | 12 |
| Post-study caffeine administration enhances memory consolidation in humans 2014 · 300 mg caffeine group · Healthy, caffeine-naive adults aged 18–30 | 300 mg | 1 day | 10 |
| The Performance Effect of Scheduled Carbohydrate and Caffeine Intake during Simulated Team Sport Match-Play 2020 · CHO + CAF · Male sub-elite hurling players, mean age 22 years | 200 mg | 1 day | 10 |
| Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers 2001 · Maintenance caffeine · Nine subjects with histories of using caffeine, tobacco, and cocaine | 300 mg | — | 9 |
| Caffeine or melatonin effects on sleep and sleepiness after rapid eastward transmeridian travel 2004 · slow-release caffeine (SRC) · Nine subjects after a seven-time-zone eastbound flight; age and sex not reported | 300 mg | 5 days | 9 |
| [Effect of acute or chronic administration of caffeine on performance and on catecholamines during maximal cycle ergometer exercise] 1990 · single caffeine administration · men undergoing maximal cycle ergometer exercise | 250 mg | 1 day | 7 |
| [Effect of acute or chronic administration of caffeine on performance and on catecholamines during maximal cycle ergometer exercise] 1990 · continuous caffeine administration · men undergoing maximal cycle ergometer exercise | 250 mg | 5 days | 7 |
| Caffeine effects on recovery sleep following 27 h total sleep deprivation 2005 · low dose caffeine · Habitually low caffeine users undergoing total sleep deprivation | 300 mg | 1 day | 6 |
| Does caffeine modify corticomotor excitability? 2006 · 400 mg caffeine group (Experiment B) · healthy controls; age and sex not specified | 400 mg | 1 day | 6 |
| The effect of repeated coffee mouth rinsing and caffeinated gum consumption on aerobic capacity and explosive power of table tennis players: a randomized, double-blind, placebo-controlled, crossover study 2024 · Caffeinated gum (CG), participants weighing more than 65 kg · Male table tennis players, mean age 21.86 years, without stated disease | 300 mg | 1 day | 5 |
| Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man 1998 · zolpidem plus caffeine 250 mg (daytime study II) · four healthy subjects; age and sex not specified | 250 mg | 1 day | 4 |
| Caffeine attenuates vasovagal reactions in female first-time blood donors 1999 · 250 mg caffeine · female undergraduate first-time blood donors | 250 mg | 1 day | — |
| Sleep loss and temporal memory 2000 · control + caffeine (Cc) · Young adults who slept normally | 350 mg | 1 day | — |
| Sleep loss and temporal memory 2000 · sleep deprived + caffeine (SDc) · Young adults assigned to 36 hours of sleep deprivation | 350 mg | 1 day | — |
| A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality 2000 · Tea equivalent to 2 cups (75 mg caffeine) · Healthy volunteers; ages and sex not specified | 300 mg | 1 day | — |
| A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality 2000 · Coffee equivalent to 1 cup (75 mg caffeine) · Healthy volunteers; ages and sex not specified | 300 mg | 1 day | — |
| The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study 2005 · fixed combination of ASA, paracetamol and caffeine · Patients who used non-prescription analgesics for episodic tension-type headache or migraine attacks; age and sex not reported | 50 mg | 1 day | — |
| The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study 2005 · caffeine · Patients who used non-prescription analgesics for episodic tension-type headache or migraine attacks; age and sex not reported | 50 mg | 1 day | — |
| Multiple caffeine doses maintain vigilance during early morning operations 2005 · 100 mg caffeine group · Adults (28 men and 20 women), sleep-deprived during an overnight operation; age and health status not reported | 300 mg | 1 day | — |
| Prior sleep with zolpidem enhances the effect of caffeine or modafinil during 18 hours continuous work 2006 · caffeine group · healthy male subjects | 300 mg | 1 day | — |
| The combined effects of L-theanine and caffeine on cognitive performance and mood 2008 · 50 mg caffeine · Healthy volunteers | 50 mg | 1 day | — |
| Headache pain model for assessing and comparing the efficacy of over-the-counter analgesic agents 1991 · aspirin with caffeine · People with muscle-contraction headache; age and sex not reported | 64 mg | 1 day | — |
| Effects of catechin enriched green tea on body composition 2010 · one serving of control drink and one serving of extra high-catechin GT1 · Moderately overweight Chinese subjects; age and sex not specified | 104 mg | 90 days | — |
| Effects of catechin enriched green tea on body composition 2010 · two servings of high-catechin GT2 · Moderately overweight Chinese subjects; age and sex not specified | 126 mg | 90 days | — |
| [Treating pain after dental surgery: a randomised, controlled, double-blind trial to assess a new formulation of paracetamol, opium powder and caffeine versus tramadol or placebo] 2010 · paracetamol 500 mg, caffeine 50mg, opium prepared 25 · Patients undergoing removal of two ipsilateral impacted third molars; age and sex not stated | 50 mg | 1 day | — |
| [Treating pain after dental surgery: a randomised, controlled, double-blind trial to assess a new formulation of paracetamol, opium powder and caffeine versus tramadol or placebo] 2010 · paracetamol 500 mg, caffeine 50mg, opium prepared 50mg · Patients undergoing removal of two ipsilateral impacted third molars; age and sex not stated | 50 mg | 1 day | — |
| Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption 2010 · Caffeine · Non-/low and medium/high habitual caffeine consumers; age and sex not stated | 250 mg | 1 day | — |
| Glucose and caffeine effects on sustained attention: an exploratory fMRI study 2010 · vehicle plus 75 mg of caffeine · Young, healthy, right-handed, low-caffeine-consuming participants; age range and sex not reported | 75 mg | 1 day | — |
| Daytime sleepiness, performance, mood, nocturnal sleep: the effect of benzodiazepine and caffeine on their relationship 1990 · caffeine group · young adult men | 250 mg | 2 days | — |
| Evaluation of aspirin, caffeine, and their combination in postoperative oral surgery pain 1990 · caffeine 65 mg · Outpatients with postoperative pain after surgical removal of impacted third molars | 65 mg | 1 day | — |
| Evaluation of aspirin, caffeine, and their combination in postoperative oral surgery pain 1990 · aspirin 650 mg with caffeine 65 mg · Outpatients with postoperative pain after surgical removal of impacted third molars | 65 mg | 1 day | — |
| Faster but not smarter: effects of caffeine and caffeine withdrawal on alertness and performance 2013 · caffeine treatment, medium-high consumers · Medium-high habitual caffeine consumers; age and sex not reported | 250 mg | 1 day | — |
| Faster but not smarter: effects of caffeine and caffeine withdrawal on alertness and performance 2013 · caffeine treatment, non-low consumers · Non-low habitual caffeine consumers; age and sex not reported | 250 mg | 1 day | — |
| Effects of caffeine and alcohol on mood and performance changes following consumption of lager 2013 · No alcohol, 125 mg caffeine per drink · Young adults aged 18–30 years; male and female; no specific condition stated | 375 mg | 1 day | — |
| Effects of oral caffeine on postdural puncture headache. A double-blind, placebo-controlled trial 1990 · oral caffeine · Postpartum patients with postdural puncture headache | 300 mg | 1 day | — |
| Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed 2013 · Caffeine at bedtime (0 hours before bedtime) · People with no stated condition; age and sex not reported | 400 mg | — | — |
| Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed 2013 · Caffeine 3 hours before bedtime · People with no stated condition; age and sex not reported | 400 mg | — | — |
| Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed 2013 · Caffeine 6 hours before bedtime · People with no stated condition; age and sex not reported | 400 mg | — | — |
| Effects of a single, oral 60 mg caffeine dose on attention in healthy adult subjects 2017 · caffeine · Healthy male and female adults aged 40–60 years with low or no caffeine consumption | 60 mg | 1 day | — |
| Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates 2017 · 60 mg caffeine group · Male inpatients with major depressive disorder taking current antidepressant medication | 60 mg | 4 weeks | — |
| The Impact of Caffeine Intake on Mental Health Symptoms in Postmenopausal Females with Overactive Bladder Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial 2022 · 400 mg/day caffeine · Postmenopausal females with overactive bladder symptoms; age range not specified | 400 mg | 7 days | — |
| Acute Cognitive Performance and Mood Effects of Coffeeberry Extract: A Randomized, Double Blind, Placebo-Controlled Crossover Study in Healthy Humans 2023 · 75 mg caffeine positive control · Healthy adults aged 18–49 years | 75 mg | 1 day | — |
| Mental effects of caffeine in fatigued and non-fatigued female and male subjects 1995 · Caffeine condition, experiment 1 · Male and female subjects; age and health status not stated | 300 mg | 1 day | — |
| Ibuprofen compared with ibuprofen plus caffeine after third molar surgery 1996 · ibuprofen 200 mg plus 50 mg of caffeine · Patients undergoing lower third molar removal | 50 mg | 1 day | — |
| Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man 1998 · caffeine 300 mg alone (daytime study I) · healthy students; age and sex not specified | 300 mg | 1 day | — |
| Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man 1998 · zolpidem plus caffeine 300 mg (daytime study I) · healthy students; age and sex not specified | 300 mg | 1 day | — |
| Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome 2018 · green/roasted coffee blend intervention · men and women aged 18–45 years with BMI 18–25 kg/m², including normocholesterolaemic and hypercholesterolaemic participants | 121 mg | 8 weeks | 52 |
| Caffeine raises blood pressure at work 1998 · 100 mg caffeine · Healthy, nonsmoking, habitual coffee drinkers; age and sex not reported | 100 mg | 2 days | 21 |
| The effect of caffeine on postprandial blood pressure in the frail elderly 1991 · caffeine · Frail elderly subjects, mean age 84 years (range 75–93); sex and specific conditions not stated | 100 mg | 1 day | 20 |
| Effects of L-theanine or caffeine intake on changes in blood pressure under physical and psychological stresses 2012 · Caffeine · Healthy adult volunteers, 22.8±2.1 years; eight men and eight women enrolled, with two women excluded from analyses | 100 mg | 1 day | 14 |
| Enhanced stimulant and metabolic effects of combined ephedrine and caffeine 2004 · caffeine · Healthy adults; age and sex distribution not specified | 200 mg | 1 day | — |
| Acute effects of commercial energy drink consumption on exercise performance and cardiovascular safety: a randomized, double-blind, placebo-controlled, crossover trial 2024 · C4E (C4 Energy drink) · Healthy, physically active men aged 20–35 years | 200 mg | 1 day | 30 |
| Acute effects of commercial energy drink consumption on exercise performance and cardiovascular safety: a randomized, double-blind, placebo-controlled, crossover trial 2024 · MED (Monster Energy caffeine drink) · Healthy, physically active men aged 20–35 years | 160 mg | 1 day | 30 |
| The effects of 600 mg of slow release caffeine on mood and alertness 1996 · caffeine group (CG) · healthy young adult males | 600 mg | 1 day | 100 |
| Panic disorder and social anxiety disorder subtypes in a caffeine challenge test 2009 · caffeine test · Adults with panic disorder, generalized social anxiety disorder or performance social anxiety disorder, and control subjects | 480 mg | 1 day | 98 |
| The use of energy drinks in sport: perceived ergogenicity and side effects in male and female athletes 2014 · caffeinated energy drink · Experienced, low-caffeine-consuming male and female athletes | 3 mg/kg | 1 day | 90 |
| The effect of caffeine on exercise performance is not influenced by ADORA2A genotypes, alone or pooled with CYP1A2 genotypes, in adolescent athletes 2023 · Caffeine (CAF) · Male adolescent athletes, mean age 15.5 ± 2 years | 6 mg/kg | 1 day | 90 |
| Randomized double-blind placebo-controlled crossover study of caffeine in patients with intermittent claudication 2010 · oral caffeine · Adults with intermittent claudication; age and sex not reported | 6 mg/kg | 1 day | 88 |
| Sex Differences in the Ergogenic Response of Acute Caffeine Intake on Muscular Strength, Power and Endurance Performance in Resistance-Trained Individuals: A Randomized Controlled Trial 2024 · caffeine (CAF) · Resistance-trained women and men aged 18–35 years who were moderate caffeine consumers and had no stated neuromuscular, musculoskeletal, neurological, immunological, or cardiometabolic disorders | 3 mg/kg | 1 day | 76 |
| ACE gene polymorphisms (rs4340) II and DI are more responsive to the ergogenic effect of caffeine than DD on aerobic power, heart rate, and perceived exertion in a homogeneous Brazilian group of adolescent athletes 2024 · caffeine (CAF) · Male adolescent athletes, ages 15–16, who regularly trained at least three times a week; ACE DD, DI, and II genotypes | 6 mg/kg | 1 day | 75 |
| Acute effects of caffeine supplementation on taekwondo performance: the influence of competition level and sex 2023 · CAF (caffeine condition) · Male and female taekwondo athletes aged 17–18, competing at elite or sub-elite level | 3 mg/kg | 1 day | 52 |
| Sex differences in the acute effect of caffeine on repeated sprint performance: A randomized controlled trial 2025 · caffeine (CAF) · Trained adults aged 24.6 ± 4.5 years; 26 women and 26 men, without diagnosed musculoskeletal, neurological, immunological, or cardiometabolic disorders | 3 mg/kg | 1 day | 52 |
| The Prophylactic Effect of Acetaminophen and Caffeine on Post Dural Puncture Headache after Spinal Anesthesia for Cesarean Section: A Randomized Double-Blind Clinical Trial 2024 · Acetaminophen+Caffeine · Parturients undergoing full-term elective cesarean delivery under spinal anesthesia | 260 mg | 1 day | 48 |
| Caffeine Intake Alters Recovery Sleep after Sleep Deprivation 2024 · caffeine (CAF) · Healthy adults aged 18–55 years, without active medical, psychiatric or sleep disorders; participants who habitually used no caffeine were included. | 5 mg/kg | 1 day | 41 |
| Evaluation of caffeine versus codeine for pain and swelling management after implant surgeries: A triple blind clinical trial 2017 · acetaminophen caffeine group · Adults aged 35–53 undergoing dental implant surgery | 80 mg | 2 days | 40 |
| Caffeine and 3-km cycling performance: Effects of mouth rinsing, genotype, and time of day 2016 · caffeine Ingestion · 38 recreational cyclists; age and sex not stated | 6 mg/kg | 1 day | 38 |
| Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882) 2021 · caffeine condition · Healthy adults aged 22–52 years without stated medical, psychiatric, or sleep disorders | 5 mg/kg | 2 days | 37 |
| Relationship between Habitual Caffeine Consumption, Attentional Performance, and Individual Alpha Frequency during Total Sleep Deprivation 2023 · caffeine (CAF) · Healthy adults aged 18–55 without medical, psychiatric, or sleep disorders | 5 mg/kg | 2 days | 37 |
| Effects of two doses of glucose and a caffeine-glucose combination on cognitive performance and mood during multi-tasking 2014 · caffeine–glucose · Healthy, non-smoking male and female adults aged 18–55 who regularly consumed caffeine | 40 mg | 1 day | 36 |
| Impact of CYP1A2 Genotypes on the Ergogenic Effects and Subjective Mood States of Caffeine Ingestion in Resistance-Trained Women 2024 · Caffeine condition (CAF) · Healthy, resistance-trained female college students aged about 22 years who habitually consumed caffeine and were not using birth control | 6 mg/kg | 1 day | 36 |
| Impact of acute caffeine intake on local tolerance to cold before and after total sleep deprivation 2025 · caffeine condition · Healthy adults aged 22–52 years, women and men, without stated cold injury or vascular disease | 5 mg/kg | 2 days | 36 |
| Effect of isolated and combined ingestion of caffeine and citrulline malate on resistance exercise and jumping performance: a randomized double-blind placebo-controlled crossover study 2023 · Caffeine · Healthy resistance-trained males and females aged 18–45 years, with at least 12 months of resistance training experience and no known medical condition | 5 mg/kg | 1 day | 35 |
| Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals 2013 · Coffee 3 · Normal-weight and overweight/obese adults; ages and sex not reported | 3 mg/kg | 1 day | 33 |
| Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals 2013 · Coffee 6 · Normal-weight and overweight/obese adults; ages and sex not reported | 6 mg/kg | 1 day | 33 |
| Ergogenic Effects of Very Low to Moderate Doses of Caffeine on Vertical Jump Performance 2023 · 1 mg/kg caffeine · Well-trained collegiate sprinters and jumpers; age and sex not specified | 1 mg/kg | 1 day | 32 |
| Ergogenic Effects of Very Low to Moderate Doses of Caffeine on Vertical Jump Performance 2023 · 3 mg/kg caffeine · Well-trained collegiate sprinters and jumpers; age and sex not specified | 3 mg/kg | 1 day | 32 |
| Ergogenic Effects of Very Low to Moderate Doses of Caffeine on Vertical Jump Performance 2023 · 6 mg/kg caffeine · Well-trained collegiate sprinters and jumpers; age and sex not specified | 6 mg/kg | 1 day | 32 |
| Effects of Carbohydrate Combined with Caffeine on the Sports Performance of Basketball Players 2026 · CAF group · Male college basketball players aged 18–25 years, without chronic disease | 3 mg/kg | 1 day | 32 |
| Effects of caffeine on performance of low intensity tasks 2002 · caffeine · College-age men and women who consumed fewer than three caffeinated beverages per week | 5 mg/kg | 1 day | 31 |
| Caffeine improves endurance in 75-yr-old citizens: a randomized, double-blind, placebo-controlled, crossover study 2005 · caffeine · Healthy men and women aged 70 years or older | 6 mg/kg | 1 day | 30 |
| A moderate dose of caffeine ingestion does not change energy expenditure but decreases sleep time in physically active males: a double-blind randomized controlled trial 2013 · caffeine condition · Physically active, nonsmoking males aged 20–39 who used less than 100 mg caffeine per day | 5 mg/kg | 4 days | 30 |
| Effect of caffeine on exercise capacity and function in prostate cancer survivors 2015 · caffeine · Prostate cancer survivors; mean age 70.3 ± 7.7 years; sex not stated | 6.04 mg/kg | 1 day | 30 |
| The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study 2019 · Caffeine (CAF) · Resistance-trained men; age not reported | 6 mg/kg | 1 day | 30 |
| Caffeine, but not paracetamol (acetaminophen), enhances muscular endurance, strength, and power 2024 · caffeine · Resistance-trained men and women aged 18–45 years, with at least 1 year of resistance-training experience and no stated health limitation | 3 mg/kg | 1 day | 29 |
| Caffeine, but not paracetamol (acetaminophen), enhances muscular endurance, strength, and power 2024 · caffeine + paracetamol · Resistance-trained men and women aged 18–45 years, with at least 1 year of resistance-training experience and no stated health limitation | 3 mg/kg | 1 day | 29 |
| Effect of coffee consumption on intraocular pressure 2002 · decaffeinated coffee · Patients with normotensive glaucoma or ocular hypertension | 3.6 mg | 1 day | 28 |
| Caffeine alters thermoregulatory responses to exercise in the heat only in caffeine-habituated individuals: a double-blind placebo-controlled trial 2021 · Caffeine (CAF) · Participants who cycled during exercise in the heat, including 14 caffeine-habituated and 14 nonhabituated individuals | 5 mg/kg | 1 day | 28 |
| Acute Co-Ingestion of Caffeine and Sodium Bicarbonate on Muscular Endurance Performance 2024 · caffeine alone (CAF) · Resistance-trained males and females aged 18–35 years | 3 mg/kg | 1 day | 28 |
| A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls 2008 · Healthy first-degree relatives of patients with panic disorder · Healthy adults who were first-degree relatives of probands with panic disorder | 480 mg | 1 day | 27 |
| Women Experience the Same Ergogenic Response to Caffeine as Men 2019 · caffeine · Endurance-trained women and men cyclists and triathletes | 3 mg/kg | 1 day | 27 |
| Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial 2023 · Caffeine citrate 10 mg/kg/day · Late preterm infants born at 34+0 to 36+6 weeks’ gestation | 10 mg/kg | — | 27 |
| Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial 2023 · Caffeine citrate 15 mg/kg/day · Late preterm infants born at 34+0 to 36+6 weeks’ gestation | 15 mg/kg | — | 27 |
| Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial 2023 · Caffeine citrate 20 mg/kg/day · Late preterm infants born at 34+0 to 36+6 weeks’ gestation | 20 mg/kg | — | 27 |
| Are caffeine effects equivalent between different modes of administration: the acute effects of 3 mg.kg(-1) caffeine on the muscular strength and power of male university Rugby Union players 2024 · CaffCAP (caffeine capsule) · Male university Rugby Union players; mean age 20 ± 2 years | 3 mg/kg | 1 day | 27 |
| Are caffeine effects equivalent between different modes of administration: the acute effects of 3 mg.kg(-1) caffeine on the muscular strength and power of male university Rugby Union players 2024 · CaffGUM (caffeinated chewing gum) · Male university Rugby Union players; mean age 20 ± 2 years | 3 mg/kg | 1 day | 27 |
| Effect of tea catechins with caffeine on energy expenditure in middle-aged men and women: a randomized, double-blind, placebo-controlled, crossover trial 2020 · Catechin treatment · Healthy men and women aged 45–65 years | 88 mg | 2 weeks | 26 |
| Energy Drinks and Their Acute Effects on Heart Rhythm and Electrocardiographic Time Intervals in Healthy Children and Teenagers: A Randomized Trial 2022 · Energy drink · Healthy children and teenagers aged 10–18 years | 3 mg/kg | 1 day | 26 |
| The dose-dependent effect of caffeine supplementation on performance, reaction time and postural stability in CrossFit - a randomized placebo-controlled crossover trial 2024 · LOW (3 mg CAF/kg BM) · Healthy, moderately CrossFit/HIFT-trained adults; 10 women and 16 men completed the study; habitual moderate caffeine intake. | 3 mg/kg | 1 day | 26 |
| The dose-dependent effect of caffeine supplementation on performance, reaction time and postural stability in CrossFit - a randomized placebo-controlled crossover trial 2024 · MEDIUM (6 mg CAF/kg BM) · Healthy, moderately CrossFit/HIFT-trained adults; 10 women and 16 men completed the study; habitual moderate caffeine intake. | 6 mg/kg | 1 day | 26 |
| The dose-dependent effect of caffeine supplementation on performance, reaction time and postural stability in CrossFit - a randomized placebo-controlled crossover trial 2024 · HIGH (9 mg CAF/kg BM) · Healthy, moderately CrossFit/HIFT-trained adults; 10 women and 16 men completed the study; habitual moderate caffeine intake. | 9 mg/kg | 1 day | 26 |
| A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls 2008 · Panic disorder patients · Adults with DSM-IV panic disorder | 480 mg | 1 day | 25 |
| The Effect of Post-Activation Potentiation Enhancement Alone or in Combination with Caffeine on Anaerobic Performance in Boxers: A Double-Blind, Randomized Crossover Study 2024 · PAPE + CAF · Male highly trained provincial- to national-level boxers, approximately 20 years old, with low habitual caffeine intake and no stated neuromuscular or musculoskeletal disorder | 3 mg/kg | 1 day | 25 |
| Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial 2023 · Caffeine citrate 5 mg/kg/day · Late preterm infants born at 34+0 to 36+6 weeks’ gestation | 5 mg/kg | — | 24 |
| Caffeine Increases Exercise Performance, Maximal Oxygen Uptake, and Oxygen Deficit in Elite Male Endurance Athletes 2021 · Caffeine · Elite endurance-trained male athletes | 4.5 mg/kg | 1 day | 23 |
| Effects of Caffeine Intake Combined with Self-Selected Music During Warm-Up on Anaerobic Performance: A Randomized, Double-Blind, Crossover Study 2025 · Music + caffeine (Mus + CAF) · Physically active men with at least 3 years of high-intensity exercise training, caffeine intake below 50 mg/day, and no stated disease | 3 mg/kg | 1 day | 23 |
| A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls 2008 · Healthy control subjects · Healthy adults with no family history of panic disorder | 480 mg | 1 day | 22 |
| Dose-dependent effect of caffeine supplementation on judo-specific performance and training activity: a randomized placebo-controlled crossover trial 2019 · 3 mg/kg caffeine · Trained male judoists; age range not reported; healthy and experienced in judo | 3 mg/kg | 1 day | 22 |
| Dose-dependent effect of caffeine supplementation on judo-specific performance and training activity: a randomized placebo-controlled crossover trial 2019 · 6 mg/kg caffeine · Trained male judoists; age range not reported; healthy and experienced in judo | 6 mg/kg | 1 day | 22 |
| Dose-dependent effect of caffeine supplementation on judo-specific performance and training activity: a randomized placebo-controlled crossover trial 2019 · 9 mg/kg caffeine · Trained male judoists; age range not reported; healthy and experienced in judo | 9 mg/kg | 1 day | 22 |
| CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance 2020 · caffeine · Resistance-trained men; age range not specified; no stated diagnosed condition | 3 mg/kg | 1 day | 22 |
| Effects of 3 mg/kg Body Mass of Caffeine on the Performance of Jiu-Jitsu Elite Athletes 2022 · caffeine condition · Elite traditional jiu-jitsu athletes aged 18–33; 11 men and 11 women | 3 mg/kg | 1 day | 22 |
| How Repeatable Is the Ergogenic Effect of Caffeine? Limited Reproducibility of Acute Caffeine (3 mg.kg(-1)) Ingestion on Muscular Strength, Power, and Muscular Endurance 2022 · caffeine · Apparently healthy male rugby union players; mean age 20 ± 2 years | 3 mg/kg | 1 day | 22 |
| CYP1A2 Genotype Variations Do Not Modify the Benefits and Drawbacks of Caffeine during Exercise: A Pilot Study 2017 · caffeine · Healthy active adults, mean age 28.9 years; 7 women; light caffeine consumers | 3 mg/kg | 1 day | 21 |
| Effects of caffeine ingestion on dynamic visual acuity: a placebo-controlled, double-blind, balanced-crossover study in low caffeine consumers 2021 · caffeine condition · Adults aged 22.5 years on average, women and men, who were low caffeine consumers and had no stated disease | 4 mg/kg | 1 day | 21 |
| Effect of caffeine on maximal strength and power in élite male athletes 1992 · caffeine · Elite male athletes; age and health condition not reported | 7 mg/kg | 1 day | 20 |
| Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes 2004 · Caffeine, patients with type 1 diabetes · Patients with long-standing type 1 diabetes | 500 mg | 2 weeks | 20 |
| Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo 2011 · Caffeine condition (caffeine, got no drug information) · Regular coffee-drinking adults aged 17–25 years; seven women; no stated diagnosed condition | 4 mg/kg | 1 day | 20 |
| Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo 2011 · Active placebo condition (caffeine, got drug information) · Regular coffee-drinking adults aged 17–25 years; seven women; no stated diagnosed condition | 4 mg/kg | 1 day | 20 |
| The effect of an acute ingestion of Turkish coffee on reaction time and time trial performance 2015 · regular Turkish coffee (TC) · Recreationally active men and women aged 18–35 who regularly consumed caffeine or coffee; otherwise generally healthy | 3 mg/kg | 1 day | 20 |
| Caffeine Improves Basketball Performance in Experienced Basketball Players 2017 · caffeine · Experienced, well-trained female and male basketball players; 10 professional women and 10 semiprofessional men, ages 27.9 ± 6.1 and 27.1 ± 4.0 years, respectively | 3 mg/kg | 1 day | 20 |
| Effects of Caffeine Supplementation on Power Performance in a Flywheel Device: A Randomised, Double-Blind Cross-Over Study 2019 · caffeine condition · healthy, active men aged 22.5 ± 4.8 years who played team sports and had resistance-training experience | 6 mg/kg | 1 day | 20 |
| The acute effects of caffeine intake on time under tension and power generated during the bench press movement 2019 · caffeine group (GCAF) · Healthy strength-trained men, aged 18 or older, with at least one year of resistance-training experience | 5 mg/kg | 1 day | 20 |
| ADOR2A C Allele Carriers Exhibit Ergogenic Responses to Caffeine Supplementation 2020 · Caffeine condition · Resistance-trained men with at least six months of resistance training experience; analysed participants were ADORA2A rs5751876 C allele carriers (CC or CT) | 3 mg/kg | 1 day | 20 |
| Similar ergogenic effect of caffeine on anaerobic performance in men and women athletes 2021 · Caffeine · Men and women athletes | 3 mg/kg | 1 day | 20 |
| The impact of daily caffeine intake on nighttime sleep in young adult men 2021 · caffeine condition · Men aged 18–35 who were healthy habitual caffeine consumers, reporting 300–600 mg daily caffeine intake | 450 mg | 10 days | 20 |
| The impact of daily caffeine intake on nighttime sleep in young adult men 2021 · withdrawal condition · Men aged 18–35 who were healthy habitual caffeine consumers, reporting 300–600 mg daily caffeine intake | 450 mg | 8 days | 20 |
| Caffeine-Induced Effects on Human Skeletal Muscle Contraction Time and Maximal Displacement Measured by Tensiomyography 2021 · experimental (EXP) · Professional male handball players, age 23.13 ± 3.51 years, high habitual caffeine consumers | 9 mg/kg | 1 day | 20 |
| Regular Caffeine Intake Delays REM Sleep Promotion and Attenuates Sleep Quality in Healthy Men 2021 · caffeine condition · Men aged 18–35 years who were healthy regular caffeine consumers, with habitual intake of 300–600 mg/day | 450 mg | 10 days | 20 |
| Short-term effects of caffeine intake on binocular accommodative facility: a quantitative and qualitative analysis 2022 · caffeine condition · University students, mean age 21.9 ± 3.4 years; no condition reported | 4 mg/kg | 1 day | 20 |
| Acute Effects of Low Dose of Caffeine Ingestion Combined with Conditioning Activity on Psychological and Physical Performances of Male and Female Taekwondo Athletes 2022 · caffeine without conditioning activity (CAF + NoCA) · Male and female taekwondo athletes aged 17–18 years; healthy, moderate caffeine consumers, with at least 6 years of experience | 3 mg/kg | 1 day | 20 |
| Acute Effects of Low Dose of Caffeine Ingestion Combined with Conditioning Activity on Psychological and Physical Performances of Male and Female Taekwondo Athletes 2022 · caffeine with conditioning activity (CAF + CA) · Male and female taekwondo athletes aged 17–18 years; healthy, moderate caffeine consumers, with at least 6 years of experience | 3 mg/kg | 1 day | 20 |
| Does Single or Combined Caffeine and Taurine Supplementation Improve Athletic and Cognitive Performance without Affecting Fatigue Level in Elite Boxers? A Double-Blind, Placebo-Controlled Study 2022 · caffeine (CAF) · Elite male boxers; mean age 22.14 ± 1.42 years | 6 mg/kg | 1 day | 20 |
| Are Caffeine's Effects on Resistance Exercise and Jumping Performance Moderated by Training Status? 2022 · caffeine · Healthy men: 10 resistance-trained men and 10 recreationally active men; ages 31 ± 6 and 24 ± 9 years, respectively. | 6 mg/kg | 1 day | 20 |
| Brain activity during a working memory task after daily caffeine intake and caffeine withdrawal: a randomized double-blind placebo-controlled trial 2023 · caffeine condition · Healthy men, mean age 26.4 years, habitual caffeine consumers | 450 mg | 10 days | 20 |
| Load and muscle group size influence the ergogenic effect of acute caffeine intake in muscular strength, power and endurance 2023 · caffeine · Resistance-trained male and female athletes, mean age 23 ± 4 years; no diagnosed condition reported | 3 mg/kg | 1 day | 20 |
| Caffeine and Beetroot Juice Optimize 1,000-m Performance: Shapley Additive Explanations Analysis 2025 · CAF group · Healthy male undergraduate students, approximately 22 years old, without a stated medical condition | 6 mg/kg | 1 day | 20 |
| The Effect of Acute Caffeine Ingestion on Tactical Performance of Professional Soccer Players 2022 · caffeine condition · Male professional soccer players, mean age 22 ± 4 years, from the Brazilian fourth division | 5 mg/kg | 1 day | 19 |
| Acute ingestion of caffeinated chewing gum reduces fatigue index and improves 400-meter performance in trained sprinters: a double-blind crossover trial 2024 · CAF trial · Professionally trained male track-and-field sprinters; mean age 20.9 ± 1.0 years, with more than 6 years of professional sprint training | 3 mg/kg | 1 day | 19 |
| Acute caffeine ingestion enhances performance and dampens muscle pain following resistance exercise to failure 2012 · caffeine condition · moderately trained males | 5 mg/kg | 1 day | 18 |
| Caffeine-containing energy drink improves physical performance in female soccer players 2014 · Caffeine-containing energy drink · Female soccer players; age range not stated | 3 mg/kg | 1 day | 18 |
| Caffeine Improved Time to Exhaustion But Did Not Change Alternative Maximal Accumulated Oxygen Deficit Estimated During a Single Supramaximal Running Bout 2016 · caffeine condition · Recreational male runners, mean age 29 ± 7 years | 6 mg/kg | 1 day | 18 |
| Effects of caffeine supplementation on physical performance and mood dimensions in elite and trained-recreational athletes 2020 · Caffeine · 18 men aged about 22 years: elite national-team boxers and trained-recreational athletes | 6 mg/kg | 1 day | 18 |
| Effect of caffeine intake on fat oxidation rate during exercise: is there a dose-response effect? 2023 · 3 mg/kg caffeine · Recreationally active males | 3 mg/kg | 1 day | 18 |
| Effect of caffeine intake on fat oxidation rate during exercise: is there a dose-response effect? 2023 · 6 mg/kg caffeine · Recreationally active males | 6 mg/kg | 1 day | 18 |
| Caffeine ingestion acutely enhances muscular strength and power but not muscular endurance in resistance-trained men 2017 · caffeine · Resistance-trained men; mean age 26 ± 6 years | 6 mg/kg | 1 day | 17 |
| Effects of Different Doses of Caffeinated Coffee on Muscular Endurance, Cognitive Performance, and Cardiac Autonomic Modulation in Caffeine Naive Female Athletes 2020 · 3COF · Healthy, resistance-trained, caffeine-naive female team-sport athletes aged 18–30 years | 3 mg/kg | 1 day | 17 |
| Effects of Different Doses of Caffeinated Coffee on Muscular Endurance, Cognitive Performance, and Cardiac Autonomic Modulation in Caffeine Naive Female Athletes 2020 · 6COF · Healthy, resistance-trained, caffeine-naive female team-sport athletes aged 18–30 years | 6 mg/kg | 1 day | 17 |
| Effect of Coffee and Tea Consumption on Adolescent Weight Control: An Interventional Pilot Study 2023 · green tea · Adolescents with obesity; median age 13 years (IQR 11–14) | 96 mg | 26 weeks | 17 |
| Ergogenic Effects of Combined Caffeine Supplementation and Motivational Music on Anaerobic Performance in Female Handball Players: A Randomized Double-Blind Controlled Trial 2025 · CAF condition · Female handball players aged 15–18 years who were low caffeine consumers | 6 mg/kg | 1 day | 17 |
| Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance 2001 · slow-release caffeine · healthy males | 600 mg | 3 days | 16 |
| Effect of caffeine on leg-muscle pain during intense cycling exercise: possible role of anxiety sensitivity 2008 · caffeine condition · college-age women completing high-intensity cycling exercise; no diagnosed condition stated | 5 mg/kg | 1 day | 16 |
| The effects of different doses of caffeine on endurance cycling time trial performance 2012 · 3 mg x kg(-1) body mass caffeine · Well-trained, familiarised male cyclists; mean age 32.6 years | 3 mg/kg | 1 day | 16 |
| The effects of different doses of caffeine on endurance cycling time trial performance 2012 · 6 mg x kg(-1) body mass caffeine · Well-trained, familiarised male cyclists; mean age 32.6 years | 6 mg/kg | 1 day | 16 |
| Acute caffeine ingestion's increase of voluntarily chosen resistance-training load after limited sleep 2012 · caffeine · 16 professional rugby players, classified by self-reported sleep as nondeprived (8 hours or more) or sleep-deprived (6 hours or less) | 4 mg/kg | 1 day | 16 |
| Caffeine-containing energy drink improves sprint performance during an international rugby sevens competition 2013 · caffeine-containing energy drink · Women aged about 23 years on the Spanish National rugby sevens team | 3 mg/kg | 1 day | 16 |
| The Effects of High Doses of Caffeine on Maximal Strength and Muscular Endurance in Athletes Habituated to Caffeine 2019 · CAF-9 · Healthy strength-trained male athletes, mean age 24.2 years, habitual caffeine consumers (4–6 mg/kg/day); no stated disease | 9 mg/kg | 1 day | 16 |
| The Effects of High Doses of Caffeine on Maximal Strength and Muscular Endurance in Athletes Habituated to Caffeine 2019 · CAF-11 · Healthy strength-trained male athletes, mean age 24.2 years, habitual caffeine consumers (4–6 mg/kg/day); no stated disease | 11 mg/kg | 1 day | 16 |
| Caffeine improves performance but not duration of the countermovement jump phases 2021 · caffeine · Resistance-trained men, mean age 22.69 years | 6 mg/kg | 1 day | 16 |
| Caffeine Doses of 3 mg/kg Increase Unilateral and Bilateral Vertical Jump Outcomes in Elite Traditional Jiu-Jitsu Athletes 2021 · caffeine condition · Elite traditional Jiu-Jitsu athletes aged 18–35 years; eight men and eight women; caffeine-naive or low habitual caffeine consumers | 3 mg/kg | 1 day | 16 |
| Effects of acute caffeine ingestion on futsal performance in sub-elite players 2021 · caffeine · male high-performance futsal players | 3 mg/kg | 1 day | 16 |
| CYP1A2 Genotype Polymorphism Influences the Effect of Caffeine on Anaerobic Performance in Trained Males 2022 · CAF · Trained males, mean age 21.6 years, without a stated medical condition | 6 mg/kg | 1 day | 16 |
| Effects of caffeine consumption combined with listening to music during warm-up on taekwondo physical performance, perceived exertion and psychological aspects 2023 · CAF+NoM (caffeine with no music) · Male elite national-team taekwondo athletes, mean age 18.25 years | 3 mg/kg | 1 day | 16 |
| Effects of caffeine consumption combined with listening to music during warm-up on taekwondo physical performance, perceived exertion and psychological aspects 2023 · CAF+M (caffeine with music) · Male elite national-team taekwondo athletes, mean age 18.25 years | 3 mg/kg | 1 day | 16 |
| Optimizing Short-Term Maximal Exercise Performance: The Superior Efficacy of a 6 mg/kg Caffeine Dose over 3 or 9 mg/kg in Young Female Team-Sports Athletes 2024 · CAF-3 · Female team-sports athletes aged 15–20 years, well-trained handball and football players, mild habitual caffeine consumers | 3 mg/kg | 1 day | 16 |
| Optimizing Short-Term Maximal Exercise Performance: The Superior Efficacy of a 6 mg/kg Caffeine Dose over 3 or 9 mg/kg in Young Female Team-Sports Athletes 2024 · CAF-6 · Female team-sports athletes aged 15–20 years, well-trained handball and football players, mild habitual caffeine consumers | 6 mg/kg | 1 day | 16 |
| Optimizing Short-Term Maximal Exercise Performance: The Superior Efficacy of a 6 mg/kg Caffeine Dose over 3 or 9 mg/kg in Young Female Team-Sports Athletes 2024 · CAF-9 · Female team-sports athletes aged 15–20 years, well-trained handball and football players, mild habitual caffeine consumers | 9 mg/kg | 1 day | 16 |
| The Effects of Caffeine on Heart Rate and Heart Rate Variability at Rest and During Submaximal Cycling Exercise 2025 · caffeine · Male cyclists, mean age 37 ± 9 years | 5 mg/kg | 1 day | 16 |
| Caffeinated chewing gum produces comparable strength and power gains to capsules with fewer side effects in resistance-trained men 2025 · Caffeine capsule (CC) · Healthy resistance-trained men aged 18–35 years with caffeine-naive or mild caffeine consumption | 4 mg/kg | 1 day | 16 |
| Caffeinated chewing gum produces comparable strength and power gains to capsules with fewer side effects in resistance-trained men 2025 · Caffeinated gum (CG) · Healthy resistance-trained men aged 18–35 years with caffeine-naive or mild caffeine consumption | 4 mg/kg | 1 day | 16 |
| Static Stretching Acutely Reduces the Ergogenic Effects of Caffeine on Sprint Performance but Not Maximal Ball Velocity in Football Players 2026 · CAF only · Male amateur football players, mean age 22.2 years, with habitual caffeine intake below approximately 1 mg/kg/day | 6 mg/kg | 1 day | 16 |
| Static Stretching Acutely Reduces the Ergogenic Effects of Caffeine on Sprint Performance but Not Maximal Ball Velocity in Football Players 2026 · CAF + SS · Male amateur football players, mean age 22.2 years, with habitual caffeine intake below approximately 1 mg/kg/day | 6 mg/kg | 1 day | 16 |
| The efficacy of acetaminophen-caffeine compared to Ibuprofen in the control of postoperative pain after periodontal surgery: a crossover pilot study 2009 · acetaminophen-caffeine group · Patients undergoing open flap debridement for periodontal surgery; age and sex not reported | 60 mg | 1 day | 15 |
| Effect of caffeine intake on pain perception during high-intensity exercise 2011 · 5 mg/kg caffeine · Active men, mean age 26.4 ± 3.9 years | 5 mg/kg | 1 day | 15 |
| Effect of caffeine intake on pain perception during high-intensity exercise 2011 · 2 mg/kg caffeine · Active men, mean age 26.4 ± 3.9 years | 2 mg/kg | 1 day | 15 |
| Enhancing physical performance in male volleyball players with a caffeine-containing energy drink 2014 · Caffeine-containing energy drink · Male college volleyball players | 3 mg/kg | 1 day | 15 |
| Caffeine ingestion improves power output decrement during 3-min all-out exercise 2016 · caffeine (CAF) · Collegiate male basketball players | 6 mg/kg | 1 day | 15 |
| Tea catechin and caffeine activate brown adipose tissue and increase cold-induced thermogenic capacity in humans 2017 · single-ingestion catechin beverage (acute trial) · Healthy men; age range not reported; assessed for brown adipose tissue activity | 77 mg | 1 day | 15 |
| Caffeine's Effects on an Upper-Body Resistance Exercise Workout 2020 · caffeine condition · Men, mean age 23.1 years, performing upper-body resistance exercise; no diagnosed condition stated | 800 mg | 1 day | 15 |
| The Acute Effect of Various Doses of Caffeine on Power Output and Velocity during the Bench Press Exercise among Athletes Habitually Using Caffeine 2019 · CAF-3 · Healthy strength-trained male basketball and handball athletes aged 26.8 ± 6.2 years who habitually consumed 4–6 mg/kg body mass of caffeine per day | 3 mg/kg | 1 day | 15 |
| The Acute Effect of Various Doses of Caffeine on Power Output and Velocity during the Bench Press Exercise among Athletes Habitually Using Caffeine 2019 · CAF-6 · Healthy strength-trained male basketball and handball athletes aged 26.8 ± 6.2 years who habitually consumed 4–6 mg/kg body mass of caffeine per day | 6 mg/kg | 1 day | 15 |
| The Acute Effect of Various Doses of Caffeine on Power Output and Velocity during the Bench Press Exercise among Athletes Habitually Using Caffeine 2019 · CAF-9 · Healthy strength-trained male basketball and handball athletes aged 26.8 ± 6.2 years who habitually consumed 4–6 mg/kg body mass of caffeine per day | 9 mg/kg | 1 day | 15 |
| Effects of caffeine on inspiratory muscle function 2020 · caffeine (CAF) · Healthy adults, mean age 24.3 years; 8 male and 7 female | 5 mg/kg | 1 day | 15 |
| Effects of Caffeine Ingestion on Physical Performance in Elite Women Handball Players: A Randomized, Controlled Study 2020 · caffeine trial · Elite women handball players | 3 mg/kg | 1 day | 15 |
| Caffeine increases strength and power performance in resistance-trained females during early follicular phase 2020 · caffeine · Resistance-trained, caffeine-habituated females, mean age 29.8 years, tested during the early follicular phase | 4 mg/kg | 1 day | 15 |
| Caffeine increases exercise intensity and energy expenditure but does not modify substrate oxidation during 1 h of self-paced cycling 2022 · caffeine · 15 young, healthy participants (11 men and 4 women) | 3 mg/kg | 1 day | 15 |
| Effects of Different Doses of Caffeine Supplementation on Collegiate Male Volleyball Players' Specific Performance and Skills: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study 2023 · low-dose caffeine (C3) · healthy male collegiate volleyball players; age range not reported | 3 mg/kg | 1 day | 15 |
| Effects of Different Doses of Caffeine Supplementation on Collegiate Male Volleyball Players' Specific Performance and Skills: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study 2023 · high-dose caffeine (C6) · healthy male collegiate volleyball players; age range not reported | 6 mg/kg | 1 day | 15 |
| Caffeinated Chewing Gum Improves Basketball Shooting Accuracy and Physical Performance Indicators of Trained Basketball Players: A Double-Blind Crossover Trial 2024 · CAF trial · Healthy adult male basketball players, mean age 20.9 ± 1.0 years, professionally trained | 3 mg/kg | 1 day | 15 |
| Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration 2024 · CAF (3 mg), morning · Female handball players aged 18–19 with low habitual caffeine consumption | 3 mg/kg | 1 day | 15 |
| Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration 2024 · CAF (3 mg), evening · Female handball players aged 18–19 with low habitual caffeine consumption | 3 mg/kg | 1 day | 15 |
| Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration 2024 · CAF (6 mg), morning · Female handball players aged 18–19 with low habitual caffeine consumption | 6 mg/kg | 1 day | 15 |
| Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration 2024 · CAF (6 mg), evening · Female handball players aged 18–19 with low habitual caffeine consumption | 6 mg/kg | 1 day | 15 |
| Caffeine is ergogenic after supplementation of oral creatine monohydrate 2002 · caffeine · trained male subjects; age and health condition not stated | 5 mg/kg | 1 day | 14 |
| Caffeine's effect on intermittent sprint cycling performance with different rest intervals 2012 · caffeine · 14 males with team sport experience | 6 mg/kg | 1 day | 14 |
| Coinciding exercise with peak serum caffeine does not improve cycling performance 2013 · C(1h) · trained male cyclists and triathletes; mean age 31±5 years | 6 mg/kg | 1 day | 14 |
| Coinciding exercise with peak serum caffeine does not improve cycling performance 2013 · C(peak) · trained male cyclists and triathletes; mean age 31±5 years | 6 mg/kg | 1 day | 14 |
| Effects of dietary nitrate, caffeine, and their combination on 20-km cycling time trial performance 2015 · caffeine · Competitive female cyclists, mean age 31 ± 7 years | 5 mg/kg | 1 day | 14 |
| Enhancing physical performance in elite junior tennis players with a caffeinated energy drink 2015 · caffeinated energy drink · 16-year-old elite-level tennis players | 3 mg/kg | 1 day | 14 |
| Caffeine supplementation and peak anaerobic power output 2015 · caffeine · Well-trained men; age and health status beyond being well-trained are not stated | 5 mg/kg | 1 day | 14 |
| Effects of acute caffeine ingestion on resistance training performance and perceptual responses during repeated sets to failure 2015 · caffeine condition · Moderately resistance-trained men, mean age 20.9 years | 5 mg/kg | 1 day | 14 |
| Acute consumption of a caffeinated energy drink enhances aspects of performance in sprint swimmers 2015 · caffeinated energy drink · male sprint swimmers | 3 mg/kg | 1 day | 14 |
| Caffeine and resistance exercise: the effects of two caffeine doses and the influence of individual perception of caffeine 2019 · CAF3 · Trained, healthy men; mean age 24.7 years | 3 mg/kg | 1 day | 14 |
| Caffeine and resistance exercise: the effects of two caffeine doses and the influence of individual perception of caffeine 2019 · CAF6 · Trained, healthy men; mean age 24.7 years | 6 mg/kg | 1 day | 14 |
| Caffeine Ingestion Improves Performance During Fitness Tests but Does Not Alter Activity During Simulated Games in Professional Basketball Players 2021 · caffeine · 14 professional male basketball players | 6 mg/kg | 1 day | 14 |
| Caffeine increases performance and leads to a cardioprotective effect during intense exercise in cyclists 2021 · Placebo–Caffeine (PC) · Male recreationally trained cyclists; mean age 34.1 years; healthy, with no stated recent cardiorespiratory, gastrointestinal, or musculoskeletal disorders | 6 mg/kg | 1 day | 14 |
| Caffeine increases performance and leads to a cardioprotective effect during intense exercise in cyclists 2021 · Caffeine–Caffeine (CC) · Male recreationally trained cyclists; mean age 34.1 years; healthy, with no stated recent cardiorespiratory, gastrointestinal, or musculoskeletal disorders | 6 mg/kg | 5 days | 14 |
| Effects of Caffeinated Chewing Gum on Ice Hockey Performance after Jet Lag Intervention: Double-Blind Crossover Trial 2024 · caffeinated chewing gum trial (CAF) · Trained ice hockey players aged 25.2 ± 5.4 years; sex not stated; professional training, without a stated diagnosed condition | 3 mg/kg | 1 day | 14 |
| Caffeine Enhances Some Aspects of Physical Performance in Well-Trained Hammer and Discus Throwers 2024 · caffeine · Well-trained adult female and male hammer and discus throwers, aged 18 or older, with at least five years of high-level competition experience | 3 mg/kg | 1 day | 14 |
| Effects of caffeine and its metabolites, theobromine and theophylline, on performance and physiological parameters in cyclists: A randomized, double-blind, placebo-controlled, crossover trial 2025 · caffeine · 14 male recreational cyclists | 6 mg/kg | 1 day | 14 |
| Effects of ephedrine, caffeine, and their combination on muscular endurance 2003 · Caffeine (C) · 13 male subjects; age and health condition not stated | 4 mg/kg | 1 day | 13 |
| The impact of prior coffee consumption on the subsequent ergogenic effect of anhydrous caffeine 2004 · DECOF + CAF (5 mg/kg) (B) · 13 subjects; age, sex and health status not specified | 5 mg/kg | — | 13 |
| The impact of prior coffee consumption on the subsequent ergogenic effect of anhydrous caffeine 2004 · colored water + CAF (5 mg/kg) (F) · 13 subjects; age, sex and health status not specified | 5 mg/kg | — | 13 |
| Caffeines enhancement of maximal voluntary strength and activation in uninjured but not injured muscle 2008 · caffeine · College students, 4 men and 9 women, undergoing trials involving experimentally uninjured and eccentric-contraction-injured knee extensor muscle | 6 mg/kg | 4 days | 13 |
| Effect of caffeine on quadriceps muscle pain during acute cycling exercise in low versus high caffeine consumers 2009 · Caffeine, low habitual caffeine consumers · College-age men who were low habitual caffeine consumers | 5 mg/kg | 1 day | 13 |
| Effect of caffeine on quadriceps muscle pain during acute cycling exercise in low versus high caffeine consumers 2009 · Caffeine, high habitual caffeine consumers · College-age men who were high habitual caffeine consumers | 5 mg/kg | 1 day | 13 |
| Improvements on neuromuscular performance with caffeine ingestion depend on the time-of-day 2015 · caffeine (morning and afternoon trials) · 13 resistance-trained males; age and health condition not reported | 6 mg/kg | 1 day | 13 |
| Caffeinated energy drinks improve volleyball performance in elite female players 2015 · caffeinated energy drink · 13 elite female volleyball players | 3 mg/kg | 1 day | 13 |
| Evaluating the effects of caffeine and sodium bicarbonate, ingested individually or in combination, and a taste-matched placebo on high-intensity cycling capacity in healthy males 2016 · CAF · Healthy, noncycling-trained males; mean age 21 ± 3 years | 5 mg/kg | 1 day | 13 |
| Acute Effect of Caffeine Supplementation on 100-m Sprint Running Performance: A Field Test 2023 · caffeine condition · Male collegiate sprinters, mean age 20.6 years, without a stated diagnosis | 6 mg/kg | 1 day | 13 |
| Pre-Exercise Caffeine Intake Attenuates the Negative Effects of Ramadan Fasting on Several Aspects of High-Intensity Short-Term Maximal Performances in Adolescent Female Handball Players 2023 · Caff (caffeine) condition · Adolescent female handball players under 18 years old who were light caffeine consumers | 6 mg/kg | 1 day | 13 |
| The Acute Effects of Caffeine Supplementation on Anaerobic Performance and Functional Strength in Female Soccer Players 2025 · Caffeine (CAF) condition · Healthy, moderately trained female football players; mean age 21.08 years | 6 mg/kg | 1 day | 13 |
| Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers 2000 · caffeine · 12 healthy male subjects, classified as habitual (n=6) or nonhabitual (n=6) caffeine consumers | 6 mg/kg | 1 day | 12 |
| Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness 2008 · caffeine · Healthy adults after 44 hours of continuous wakefulness | 600 mg | 1 day | 12 |
| Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil 2008 · caffeine · Healthy adults aged 18 to 36 | 600 mg | 1 day | 12 |
| Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil 2009 · caffeine · Healthy adults aged 18–36 years after 44 hours awake | 600 mg | 1 day | 12 |
| Caffeine enhances cognitive function and skill performance during simulated soccer activity 2009 · caffeine (CAF) · 12 male soccer players | 6 mg/kg | 1 day | 12 |
| Caffeine withdrawal and high-intensity endurance cycling performance 2011 · placebo-caffeine condition · Well-trained, familiarised male cyclists who were habitual caffeine consumers | 3 mg/kg | 1 day | 12 |
| Caffeine withdrawal and high-intensity endurance cycling performance 2011 · caffeine-placebo condition · Well-trained, familiarised male cyclists who were habitual caffeine consumers | 1.5 mg/kg | 4 days | 12 |
| Caffeine ingestion, affect and perceived exertion during prolonged cycling 2011 · CAF trial · 12 endurance-trained adult male cyclists | 6 mg/kg | 1 day | 12 |
| Caffeine ingestion reverses the circadian rhythm effects on neuromuscular performance in highly resistance-trained men 2012 · AMCAFF trial · Highly resistance-trained men, mean age 19.7 years; light caffeine consumers | 3 mg/kg | 1 day | 12 |
| Cortical substrates of the effects of caffeine and time-on-task on perception of effort 2014 · caffeine · 12 healthy female volunteers | 6 mg/kg | 1 day | 12 |
| Improvement of Sprint Performance in Wheelchair Sportsmen With Caffeine Supplementation 2016 · caffeine (CAF) · Male wheelchair rugby players, mean age 30.0 years | 4 mg/kg | 1 day | 12 |
| Effects of strategic early-morning caffeine gum administration on association between salivary alpha-amylase and neurobehavioural performance during 50 h of sleep deprivation 2019 · caffeine condition · 23 healthy adults undergoing 50 hours of total sleep deprivation; 12 received caffeine | 800 mg | 2 days | 12 |
| The acute effects of plyometric and sled towing stimuli with and without caffeine ingestion on vertical jump performance in professional soccer players 2018 · Caffeine condition · Male professional soccer players with habitual caffeine intake below 250 mg/day; ages not specified | 5 mg/kg | 1 day | 12 |
| Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48 h of total sleep deprivation 2019 · 300 mg caffeine condition · Healthy adults aged 18–39 years, six women and six men, without a stated diagnosed condition | 600 mg | 2 days | 12 |
| Cardiac autonomic activity during sleep deprivation with and without caffeine administration 2019 · 300 mg caffeine · Healthy adults aged 19–39 years, women and men | 600 mg | 2 days | 12 |
| Acute Caffeine Intake Enhances Mean Power Output and Bar Velocity during the Bench Press Throw in Athletes Habituated to Caffeine 2020 · CAF-3 · Healthy strength-trained male athletes aged 25.3 ± 1.7 years, habituated to caffeine | 3 mg/kg | 1 day | 12 |
| Acute Caffeine Intake Enhances Mean Power Output and Bar Velocity during the Bench Press Throw in Athletes Habituated to Caffeine 2020 · CAF-6 · Healthy strength-trained male athletes aged 25.3 ± 1.7 years, habituated to caffeine | 6 mg/kg | 1 day | 12 |
| Caffeine Exacerbates Hyperventilation and Reductions in Cerebral Blood Flow in Physically Fit Men Exercising in the Heat 2021 · caffeine trial · Physically active healthy young men, age 23 ± 2 years | 5 mg/kg | 1 day | 12 |
| Placebo Effect of Caffeine on Substrate Oxidation during Exercise 2021 · received caffeine · 12 young men aged 23 ± 5 years who exercised regularly and had low daily caffeine consumption | 3 mg/kg | 1 day | 12 |
| Acute effects of two caffeine doses on bar velocity during the bench press exercise among women habituated to caffeine: a randomized, crossover, double-blind study involving control and placebo conditions 2022 · CAF-3 · Healthy resistance-trained women habituated to caffeine; mean age 23.3 years | 3 mg/kg | 1 day | 12 |
| Acute effects of two caffeine doses on bar velocity during the bench press exercise among women habituated to caffeine: a randomized, crossover, double-blind study involving control and placebo conditions 2022 · CAF-6 · Healthy resistance-trained women habituated to caffeine; mean age 23.3 years | 6 mg/kg | 1 day | 12 |
| Caffeine alters the breathing pattern during high-intensity whole-body exercise in healthy men 2022 · caffeine · 12 healthy men; age not stated | 5 mg/kg | 1 day | 12 |
| The Effect of Creatine Nitrate and Caffeine Individually or Combined on Exercise Performance and Cognitive Function: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial 2024 · combination of creatine nitrate and caffeine (CO) · resistance-trained males aged 18–40 without the listed metabolic or cardiovascular conditions | 400 mg | 7 days | 12 |
| Caffeine ingestion compromises thermoregulation and does not improve cycling time to exhaustion in the heat amongst males 2024 · caffeine condition · healthy, recreationally active males; mean age 23 ± 4 years | 5 mg/kg | 1 day | 12 |
| Dose-response effects of caffeine during repeated cycling sprints in normobaric hypoxia to exhaustion 2025 · LOW (3 mg/kg caffeine) · 12 active males; age and health condition not specified | 3 mg/kg | 1 day | 12 |
| Dose-response effects of caffeine during repeated cycling sprints in normobaric hypoxia to exhaustion 2025 · MOD (6 mg/kg caffeine) · 12 active males; age and health condition not specified | 6 mg/kg | 1 day | 12 |
| Dose-response effects of caffeine during repeated cycling sprints in normobaric hypoxia to exhaustion 2025 · HIGH (9 mg/kg caffeine) · 12 active males; age and health condition not specified | 9 mg/kg | 1 day | 12 |
| Effects of Caffeine Ingestion on Pulmonary V˙O2 Kinetics and Muscle Fatigue During Severe-Intensity Cycling Exercise 2025 · caffeine (CAF) · Physically active men, mean age 26 ± 5 years | 6 mg/kg | 1 day | 12 |
| Effects of the Combined Supplementation of Caffeine and Rhodiola Rosea with Resistance Training on Lower Limb Explosive Power in Male Volleyball Players 2025 · Caffeine Group (CAF) · Male volleyball athletes aged 18–23 years, Chinese first-class athletes with at least two years of professional training experience | 3 mg/kg | 4 weeks | 12 |
| In-Exercise Caffeine Improves Exercise Performance in the Heat without Exacerbating Hyperventilation and Brain Hypoperfusion 2025 · caffeine trial · Healthy young adults; 5 of the 12 participants were female. | 5 mg/kg | 1 day | 12 |
| Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans 1997 · 500 mg of caffeine · 12 healthy volunteers; age range and sex not reported | 500 mg | 1 day | 12 |
| Acute effects of caffeine ingestion on signal-averaged electrocardiograms 1998 · caffeine · Healthy adults aged 21–26 years, 6 men and 6 women | 5 mg/kg | 1 day | 12 |
| Caffeine consumption decreases the response to bronchoprovocation challenge with dry gas hyperventilation 1991 · 5 mg/kg caffeine · Nonsmoking men aged 18 to 42 years with normal baseline spirometry and evidence of exercise-induced bronchospasm | 5 mg/kg | 1 day | 11 |
| Caffeine consumption decreases the response to bronchoprovocation challenge with dry gas hyperventilation 1991 · 10 mg/kg caffeine · Nonsmoking men aged 18 to 42 years with normal baseline spirometry and evidence of exercise-induced bronchospasm | 10 mg/kg | 1 day | 11 |
| Effect of ambient temperature on caffeine ergogenicity during endurance exercise 2011 · caffeine · Male cyclists, mean age 25 ± 6 years | 6 mg/kg | 1 day | 11 |
| Acute caffeine ingestion enhances strength performance and reduces perceived exertion and muscle pain perception during resistance exercise 2013 · caffeine condition · Resistance-trained adults, 9 males and 2 females, mean age 26.4 years | 5 mg/kg | 1 day | 11 |
| The effects of Red Bull energy drink compared with caffeine on cycling time-trial performance 2015 · Red Bull · trained male cyclists, mean age 31.7 years | 3 mg/kg | 1 day | 11 |
| The effects of Red Bull energy drink compared with caffeine on cycling time-trial performance 2015 · Anhydrous caffeine · trained male cyclists, mean age 31.7 years | 3 mg/kg | 1 day | 11 |
| Effects of sodium phosphate and caffeine ingestion on repeated-sprint ability in male athletes 2016 · Caffeine · Male team-sport athletes | 6 mg/kg | 1 day | 11 |
| Time course of tolerance to the performance benefits of caffeine 2019 · caffeine protocol · Healthy active adults, mean age 32.3 years, including women and men; light caffeine consumers (<50 mg/day), without stated disease | 3 mg/kg | 20 days | 11 |
| Effect of caffeine on neuromuscular function following eccentric-based exercise 2019 · Caffeine (CAF) · Well-trained male sprinters and jumpers, mean age 18.7 years, with low-to-moderate habitual caffeine consumption | 5 mg/kg | 3 days | 11 |
| The Effects of Caffeine on Jumping Performance and Maximal Strength in Female Collegiate Athletes 2021 · Caffeine condition · Female collegiate volleyball players and weightlifters; ages not reported; no diagnosed condition stated | 6 mg/kg | 1 day | 11 |
| Effects of Caffeinated Coffee on Cross-Country Cycling Performance in Recreational Cyclists 2024 · caffeinated coffee (CAF) · Healthy, physically active recreational cross-country cyclists aged 18–30 years, with low habitual caffeine intake | 3 mg/kg | 1 day | 11 |
| Opposite actions of caffeine and creatine on muscle relaxation time in humans 2002 · Caf · healthy male volunteers | 5 mg/kg | 3 days | 10 |
| Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine 2002 · caffeine 600 mg · healthy young adults | 600 mg | 1 day | 10 |
| Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes 2004 · Caffeine, healthy volunteers · Matched healthy volunteers | 500 mg | 2 weeks | 10 |
| Caffeine increases time to fatigue by maintaining force and not by altering firing rates during submaximal isometric contractions 2005 · caffeine · 10 male volunteers; age and health condition not specified | 6 mg/kg | 1 day | 10 |
| Caffeine effects on physical and cognitive performance during sustained operations 2007 · CAF group · Special Forces soldiers aged 28.6 ± 4.7 years undergoing sustained operations with overnight wakefulness and restricted daytime sleep | 800 mg | 4 days | 10 |
| Effects of caffeine on repeated sprint ability, reactive agility time, sleep and next day performance 2010 · caffeine · moderately trained male athletes | 6 mg/kg | 1 day | 10 |
| Effect of caffeine on reactive agility time when fresh and fatigued 2011 · caffeine · Moderately trained male team-sport athletes | 6 mg/kg | 1 day | 10 |
| Caffeine increases performance in cross-country double-poling time trial exercise 2013 · Caffeine (CAF) trial · Ten highly trained male cross-country skiers | 6 mg/kg | 1 day | 10 |
| Effect of caffeine ingestion on torque and muscle activity during resistance exercise in men 2014 · caffeine · trained men, mean age 22 years | 6 mg/kg | 1 day | 10 |
| Caffeine reduces reaction time and improves performance in simulated-contest of taekwondo 2014 · caffeine · Male taekwondo athletes; mean age 24.9 years; at least 7 years of experience | 5 mg/kg | 1 day | 10 |
| Tea catechin and caffeine activate brown adipose tissue and increase cold-induced thermogenic capacity in humans 2017 · catechin beverage twice daily (chronic trial) · Men with low brown adipose tissue activity; age range not reported | 154 mg | 5 weeks | 10 |
| Effects of Caffeine on Countermovement-Jump Performance Variables in Elite Male Volleyball Players 2018 · caffeine · Elite male volleyball players; age and health condition not stated | 5 mg/kg | 1 day | 10 |
| Caffeine ingestion changes time-motion and technical-tactical aspects in simulated boxing matches: A randomized double-blind PLA-controlled crossover study 2018 · caffeine (CAF) condition · Male boxers; age and health condition not stated | 6 mg/kg | 1 day | 10 |
| Acute caffeine supplementation promotes small to moderate improvements in performance tests indicative of in-game success in professional female basketball players 2019 · caffeine · professional female basketball players | 3 mg/kg | 1 day | 10 |
| Caffeine Ingestion Affects Performance in Different Parts of a Novel Multidirectional High-Intensity Intermittent Exercise in Futsal Athletes 2022 · caffeine · Futsal athletes; age and sex not reported | 6 mg/kg | 1 day | 10 |
| Preliminary Research towards Acute Effects of Different Doses of Caffeine on Strength-Power Performance in Highly Trained Judo Athletes 2022 · CAF-3 · Highly trained national-level judoka; 6 men and 4 women, aged range not reported | 3 mg/kg | 1 day | 10 |
| Preliminary Research towards Acute Effects of Different Doses of Caffeine on Strength-Power Performance in Highly Trained Judo Athletes 2022 · CAF-6 · Highly trained national-level judoka; 6 men and 4 women, aged range not reported | 6 mg/kg | 1 day | 10 |
| Effect of caffeine ingestion on perception of effort and subsequent work production 1996 · caffeine trials · 10 subjects performing cycling exercise; age, sex, and health status not specified | 6 mg/kg | 1 day | 10 |
| Effect of repeated caffeine ingestion on repeated exhaustive exercise endurance 2003 · Trial C: caffeine in the AM and placebo in the PM · Nine male caffeine users | 5 mg/kg | — | 9 |
| Effect of repeated caffeine ingestion on repeated exhaustive exercise endurance 2003 · Trial D: placebo in the AM and caffeine in the PM · Nine male caffeine users | 5 mg/kg | — | 9 |
| Multiple effects of caffeine on simulated high-intensity team-sport performance 2005 · caffeine · competitive male rugby players; age and health status not specified | 6 mg/kg | 1 day | 9 |
| Effect of caffeine ingestion on anaerobic capacity quantified by different methods 2017 · caffeine · Recreationally active men; mean age 26.8 years; no diagnosed condition stated | 5 mg/kg | 1 day | 9 |
| Caffeine supplementation improves the cognitive abilities and shooting performance of elite e-sports players: a crossover trial 2024 · caffeine trial (CAF) · Healthy male adults aged 20–22 years, elite first-person shooter e-sports players | 3 mg/kg | 1 day | 9 |
| Caffeinated Ice Slushy Enhances 1,200 kJ Cycle Time-Trial Performance in the Heat 2025 · CAF · Nine moderately trained recreational male cyclists or triathletes | 3 mg/kg | 1 day | 9 |
| The effect of different dosages of caffeine on endurance performance time 1995 · 5 mg/kg caffeine · Well-trained cyclists; age and sex not reported | 5 mg/kg | 1 day | 9 |
| The effect of different dosages of caffeine on endurance performance time 1995 · 9 mg/kg caffeine · Well-trained cyclists; age and sex not reported | 9 mg/kg | 1 day | 9 |
| The effect of different dosages of caffeine on endurance performance time 1995 · 13 mg/kg caffeine · Well-trained cyclists; age and sex not reported | 13 mg/kg | 1 day | 9 |
| The effects of caffeine on the maximal accumulated oxygen deficit and short-term running performance 1998 · caffeine condition · Nine well-trained males; age and health condition not stated | 5 mg/kg | 1 day | 9 |
| Enhancement of 2000-m rowing performance after caffeine ingestion 2000 · 6 mg/kg caffeine · competitive male rowers; age not reported; no diagnosed condition stated | 6 mg/kg | 1 day | 8 |
| Enhancement of 2000-m rowing performance after caffeine ingestion 2000 · 9 mg/kg caffeine · competitive male rowers; age not reported; no diagnosed condition stated | 9 mg/kg | 1 day | 8 |
| Central excitability does not limit postfatigue voluntary activation of quadriceps femoris 2006 · caffeine trial · Eight men; no diagnosed condition stated | 6 mg/kg | 1 day | 8 |
| The effect of caffeine ingestion on 8 km run performance in a field setting 2006 · caffeine capsule · male distance runners | 3 mg/kg | 1 day | 8 |
| The effects of caffeine ingestion on time trial cycling performance 2008 · Caffeine (CAF) · Eight well-trained male cyclists, mean age 30.2 years | 6 mg/kg | 1 day | 8 |
| No effect of caffeine on exercise performance in high ambient temperature 2011 · caffeine · healthy trained male cyclists | 6 mg/kg | 1 day | 8 |
| The metabolic and performance effects of caffeine compared to coffee during endurance exercise 2013 · caffeine (CAF) · trained male and female cyclists/triathletes, mean age 41±7 years, with low habitual caffeine intake (≤300 mg/day) | 5 mg/kg | 1 day | 8 |
| Caffeine alters anaerobic distribution and pacing during a 4000-m cycling time trial 2013 · caffeine (CAF) · Eight trained male cyclists; age 32.6 ± 5.4 years on average; no diagnosed condition stated | 5 mg/kg | 1 day | 8 |
| Caffeine and performance over consecutive days of simulated competition 2014 · CAF3 · Highly trained male cross-country skiers; age and health condition not stated | 3 mg/kg | 2 days | 8 |
| Caffeine and performance over consecutive days of simulated competition 2014 · CAF4.5 · Highly trained male cross-country skiers; age and health condition not stated | 4.5 mg/kg | 2 days | 8 |
| Carbohydrate mouth rinse and caffeine improves high-intensity interval running capacity when carbohydrate restricted 2016 · CAFF + CMR · Eight male participants; age and health condition not stated | 400 mg | 1 day | 8 |
| Effect of a moderate caffeine dose on endurance cycle performance and thermoregulation during prolonged exercise in the heat 2017 · caffeine trial · Healthy, recreationally active males; mean age 22 years | 6 mg/kg | 1 day | 8 |
| Caffeine Supplementation Improves Anaerobic Performance and Neuromuscular Efficiency and Fatigue in Olympic-Level Boxers 2019 · caffeine condition · Eight healthy male Olympic-level boxers, age 22.0 ± 1.778 years | 6 mg/kg | 1 day | 8 |
| Caffeine and sodium bicarbonate supplementation alone or together improve karate performance 2019 · CAF · Karatekas aged 20.5 ± 2.4 years; sex not specified; experienced competitive karate athletes | 6,000 mg/kg | 1 day | 8 |
| Addition of Caffeine to a Carbohydrate Feeding Strategy Prior to Intermittent Exercise 2020 · Caffeine condition · Recreational soccer players; age and sex not reported | 5 mg/kg | 1 day | 8 |
| Low caffeine dose improves intermittent sprint performance in hot and humid environments 2020 · caffeine condition · Male soccer players, mean age 19.9 years | 3 mg/kg | 1 day | 8 |
| Caffeine Improves Sprint Time in Simulated Freestyle Swimming Competition but Not the Vertical Jump in Female Swimmers 2024 · caffeine condition · healthy, moderately trained female swimmers; mean age 21.3 ± 1.4 years | 6 mg/kg | 1 day | 8 |
| Caffeine supplementation during official basketball games: a randomized crossover study on the effects on game-related statistics and perceptual responses of adult male players 2024 · CAF · Adult male semiprofessional basketball players, mean age 23.5 ± 5.7 years | 3 mg/kg | 1 day | 8 |
| The Effect of Pre-Exercise Caffeine and Glucose Ingestion on Endurance Capacity in Hypoxia: A Double-Blind Crossover Trial 2024 · caffeine (Caff) · Healthy, active, recreationally trained collegiate males, mean age 21.9 years | 6 mg/kg | 1 day | 8 |
| Systemic and regional haemodynamic effects of caffeine and alcohol in fasting subjects [corrected] 1995 · coffee containing caffeine · Eight healthy young subjects; sex and age range not reported | 3.5 mg/kg | 1 day | 8 |
| Effects of caffeine ingestion on exercise-induced changes during high-intensity, intermittent exercise 1995 · caffeine trial · trained male subjects; age and condition not specified | 5 mg/kg | 1 day | 8 |
| Effects of caffeine on time to exhaustion in exercise performed below and above the anaerobic threshold 1998 · caffeine (CAF) · Eight untrained males who were non-regular caffeine consumers | 5 mg/kg | 1 day | 8 |
| Performance and metabolic responses to a high caffeine dose during prolonged exercise 1991 · caffeine (CAF) · Well-trained competitive runners; adult age and sex not specified | 9 mg/kg | 1 day | 7 |
| Caffeine increases anaerobic work and restores cycling performance following a protocol designed to lower endogenous carbohydrate availability 2013 · DEP-CAF (low carbohydrate availability with caffeine ingestion) · Amateur cyclists aged 32.3±5.4 years, all sexes not specified; trained and regularly competing, without a stated diagnosed condition | 5 mg/kg | 1 day | 7 |
| Combined effect of coffee ingestion and repeated bouts of low-intensity exercise on fat oxidation 2017 · CS (coffee; single 30-min bout of exercise) · Seven young, healthy male adults | 5 mg/kg | 1 day | 7 |
| Combined effect of coffee ingestion and repeated bouts of low-intensity exercise on fat oxidation 2017 · CR (coffee; three 10-min bouts of exercise) · Seven young, healthy male adults | 5 mg/kg | 1 day | 7 |
| Effects of caffeine on neuromuscular fatigue and performance during high-intensity cycling exercise in moderate hypoxia 2017 · caffeine condition · Healthy recreationally active males, mean age 29 ± 6 years, with moderate caffeine consumption; lifelong sea-level residents | 4 mg/kg | 1 day | 7 |
| The Effects of Caffeine, Taurine, or Caffeine-Taurine Coingestion on Repeat-Sprint Cycling Performance and Physiological Responses 2017 · C (caffeine) · Seven male team-sport players | 5 mg/kg | 1 day | 7 |
| Caffeine effects on recovery sleep following 27 h total sleep deprivation 2005 · high dose caffeine · Habitually low caffeine users undergoing total sleep deprivation | 900 mg | 1 day | 6 |
| Effects of caffeine ingestion on performance and anaerobic metabolism during the Wingate Test 1991 · caffeine · Six healthy, nonspecifically trained volunteers | 5 mg/kg | 1 day | 6 |
| The effect of adding caffeine to postexercise carbohydrate feeding on subsequent high-intensity interval-running capacity compared with carbohydrate alone 2011 · CHO+CAFF · Six men; age and health condition not reported; performed glycogen-depleting exercise | 32 mg/kg | 1 day | 6 |
| Caffeine Attenuates Decreases in Leg Power Without Increased Muscle Damage 2016 · caffeine (CAF) · Six male handball athletes; age and health condition not stated | 6 mg/kg | 1 day | 6 |
| Effects of Creatine and Caffeine Supplementation During Resistance Training on Body Composition, Strength, Endurance, Rating of Perceived Exertion and Fatigue in Trained Young Adults 2022 · CAF (caffeine) · Trained young adults; mean age 19 ± 1 years; sex not specified | 3 mg/kg | 6 weeks | 6 |
| Caffeine supplementation improved movement patterns and reactive agility in rugby sevens matches in male collegiate players 2025 · caffeine trial · Male collegiate rugby players, mean age 21.5 years, without stated major cardiovascular or metabolic disease; six players were included in the analysis | 6 mg/kg | 2 days | 6 |
| Effect of caffeine on metabolism, exercise endurance, and catecholamine responses after withdrawal 1998 · Caffeine · Recreational athletes who were habitual caffeine users; sex and age not reported | 6 mg/kg | 1 day | 6 |
| Effects of caffeine or ethanol on treadmill performance and metabolic responses of well-trained men 1994 · Caffeine condition · Four trained men who were runners | 5 mg/kg | 1 day | 4 |
| A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality 2000 · Coffee equivalent to 2 cups (150 mg caffeine) · Healthy volunteers; ages and sex not specified | 600 mg | 1 day | — |
| Caffeine as a lipolytic food component increases endurance performance in rats and athletes 2001 · caffeine trial · athletes; age, sex, and health condition not stated | 5 mg/kg | 1 day | — |
| Effects of caffeine on performance and mood depend on the level of caffeine abstinence 2002 · 1 mg/kg caffeine at breakfast, followed by placebo · Moderate caffeine consumers who were caffeine-deprived at testing; age and sex not reported | 1 mg/kg | 1 day | — |
| Effects of caffeine on performance and mood depend on the level of caffeine abstinence 2002 · 2 mg/kg caffeine at breakfast, followed by placebo · Moderate caffeine consumers who were caffeine-deprived at testing; age and sex not reported | 2 mg/kg | 1 day | — |
| Effects of caffeine on performance and mood depend on the level of caffeine abstinence 2002 · Placebo at breakfast, followed by 1 mg/kg caffeine · Moderate caffeine consumers who were caffeine-deprived at testing; age and sex not reported | 1 mg/kg | 1 day | — |
| The effect of caffeine on the cardiovascular responses to head-up tilt 2003 · chronic caffeine · 16 subjects; age, sex, and health status not specified | 5 mg/kg | 7 days | — |
| The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial 1992 · caffeine · Obese patients | 600 mg | 24 weeks | — |
| Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition 2004 · C&E group (phase II and phase III) · Adults with BMI 25 to 35 kg/m2; healthy subjects, ages and sex not stated | 210 mg | 174 days | — |
| Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition 2004 · Placebo group given C&E in phase III · Adults with BMI 25 to 35 kg/m2; healthy subjects, ages and sex not stated | 210 mg | 26 weeks | — |
| Multiple caffeine doses maintain vigilance during early morning operations 2005 · 200 mg caffeine group · Adults (28 men and 20 women), sleep-deprived during an overnight operation; age and health status not reported | 600 mg | 1 day | — |
| Ergogenic effects of low doses of caffeine on cycling performance 2008 · 1 mg/kg caffeine · Cyclists; age, sex, and health status not specified | 1 mg/kg | 1 day | — |
| Ergogenic effects of low doses of caffeine on cycling performance 2008 · 2 mg/kg caffeine · Cyclists; age, sex, and health status not specified | 2 mg/kg | 1 day | — |
| Ergogenic effects of low doses of caffeine on cycling performance 2008 · 3 mg/kg caffeine · Cyclists; age, sex, and health status not specified | 3 mg/kg | 1 day | — |
| The combined effects of L-theanine and caffeine on cognitive performance and mood 2008 · 50 mg caffeine plus 100 mg L-theanine · Healthy volunteers | 50 mg | 1 day | — |
| Caffeine supplementation and multiple sprint running performance 2008 · caffeine · Physically active men; age and health condition not stated | 5 mg/kg | 1 day | — |
| Modeling fatigue over sleep deprivation, circadian rhythm, and caffeine with a minimal performance inhibitor model 2009 · caffeine group · Adults who were mild or noncaffeine users (<300 mg/day); 14 males and 4 females across the study, with ages not reported. | 800 mg | 3 days | — |
| Effects of catechin enriched green tea on body composition 2010 · two servings of extra high-catechin GT3 · Moderately overweight Chinese subjects; age and sex not specified | 198 mg | 90 days | — |
| Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour 2011 · high-dose group · Infants born before 30 weeks’ gestation with apnoea of prematurity or in the peri-extubation period | 20 mg/kg | — | — |
| Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour 2011 · low-dose group · Infants born before 30 weeks’ gestation with apnoea of prematurity or in the peri-extubation period | 5 mg/kg | — | — |
| Glucose and caffeine effects on sustained attention: an exploratory fMRI study 2010 · vehicle plus 75 g of glucose and 75 mg of caffeine · Young, healthy, right-handed, low-caffeine-consuming participants; age range and sex not reported | 75 mg | 1 day | — |
| Effects of caffeine on alertness 1990 · caffeine 250 mg · healthy young men | 500 mg | 2 days | — |
| Effects of ingested doses of caffeine on neuromuscular reflex response time in man 1990 · 3 mg/kg caffeine group · College-age, caffeine-naive participants; sex and condition not specified | 3 mg/kg | 1 day | — |
| Effects of ingested doses of caffeine on neuromuscular reflex response time in man 1990 · 6 mg/kg caffeine group · College-age, caffeine-naive participants; sex and condition not specified | 6 mg/kg | 1 day | — |
| Cardiovascular responses to caffeine by gender and pubertal stage 2014 · 1 mg/kg caffeine · Prepubertal boys and girls aged 8–9 years and postpubertal boys and girls aged 15–17 years | 1 mg/kg | 1 day | — |
| Cardiovascular responses to caffeine by gender and pubertal stage 2014 · 2 mg/kg caffeine · Prepubertal boys and girls aged 8–9 years and postpubertal boys and girls aged 15–17 years | 2 mg/kg | 1 day | — |
| Effects of different doses of caffeine on anaerobic exercise in boys 2015 · CAF-1 · Boys aged 8–10 years | 1 mg/kg | 1 day | — |
| Effects of different doses of caffeine on anaerobic exercise in boys 2015 · CAF-3 · Boys aged 8–10 years | 3 mg/kg | 1 day | — |
| Effects of different doses of caffeine on anaerobic exercise in boys 2015 · CAF-5 · Boys aged 8–10 years | 5 mg/kg | 1 day | — |
| Caffeinated nitric oxide-releasing lozenge improves cycling time trial performance 2015 · caffeinated nitric oxide lozenge · 15 moderately trained cyclists, 7 female and 8 male | 70 mg | 1 day | — |
| Prospective study on the effects of regular and decaffeinated coffee on urinary symptoms in young and healthy volunteers 2017 · regular coffee · Young, healthy volunteers; low and frequent prior coffee users | 450 mg | 5 days | — |
| Prospective study on the effects of regular and decaffeinated coffee on urinary symptoms in young and healthy volunteers 2017 · decaffeinated coffee · Young, healthy volunteers; low and frequent prior coffee users | 12 mg | 5 days | — |
| Caffeine administration at night during extended wakefulness effectively mitigates performance impairment but not subjective assessments of fatigue and sleepiness 2016 · caffeine · Non-smoking adults, mean age 22.5 years, undergoing 50 hours of extended wakefulness | 800 mg | 2 days | — |
| Chronic ingestion of a low dose of caffeine induces tolerance to the performance benefits of caffeine 2017 · caffeine supplementation group · low-habitual caffeine consumers; age and sex not specified | 1.5 mg/kg | 4 weeks | — |
| The Acute Effects of Caffeinated Black Coffee on Cognition and Mood in Healthy Young and Older Adults 2018 · decaffeinated coffee · Healthy habitual caffeine-consuming adults aged 20–34 or 61–80 years, men and women | 5 mg | 1 day | — |
| Effects of caffeine and sex on muscle performance and delayed-onset muscle soreness after exercise-induced muscle damage: a double-blind randomized trial 2019 · caffeine · Healthy elite college athletes, 10 male and 10 female; age not reported; exercise-induced muscle damage | 6 mg/kg | 2 days | — |
| Acute Effects of Caffeine on Dynamic Accommodative Response and Pupil Size: A Placebo-controlled, Double-blind, Balanced Crossover Study 2020 · caffeine condition · University students, mean age 21.68 ± 3.67 years; no specific condition reported | 4 mg/kg | 1 day | — |
| Oral caffeine intake amplifies the effect of isoproterenol in patients with frequent premature ventricular contractions 2020 · caffeine · Adults undergoing catheter ablation for monofocal premature ventricular contractions; mean age 54 ± 14 years | 5 mg/kg | 1 day | — |
| Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C > A CYP1A2 genotypes 2020 · caffeine · Adolescent athletes aged 15 ± 2 years | 6 mg/kg | 1 day | — |
| Effect of acute caffeine intake on hit accuracy and reaction time in professional e-sports players 2020 · caffeine · Professional e-sports players, mean age 22 ± 3 years | 3 mg/kg | 1 day | — |
| Caffeine, exercise physiology, and time-trial performance: no effect of ADORA2A or CYP1A2 genotypes 2021 · caffeine · male cyclists; age and health condition not stated | 5 mg/kg | 1 day | — |
| Transcranial Direct Current Stimulation Combined With or Without Caffeine: Effects on Training Volume and Pain Perception 2023 · Sham tDCS with caffeine intake (Sham+Caff) · Healthy, resistance-trained males; mean age 25.2 years | 5 mg/kg | 1 day | — |
| Transcranial Direct Current Stimulation Combined With or Without Caffeine: Effects on Training Volume and Pain Perception 2023 · Anodal tDCS with caffeine intake (a-tDCS+Caff) · Healthy, resistance-trained males; mean age 25.2 years | 5 mg/kg | 1 day | — |
| Caffeine Enhances Intermittent Hypoxia-Induced Gains in Walking Function for People with Chronic Spinal Cord Injury 2022 · caffeine + AIH · People with chronic (≥1 year) incomplete spinal cord injury | 4 mg/kg | 5 days | — |
| Caffeine Enhances Intermittent Hypoxia-Induced Gains in Walking Function for People with Chronic Spinal Cord Injury 2022 · caffeine + SHAM · People with chronic (≥1 year) incomplete spinal cord injury | 4 mg/kg | 5 days | — |
| Repeated low-dose caffeine ingestion during a night of total sleep deprivation improves endurance performance and cognitive function in young recreational runners: A randomized, double-blind, placebo-controlled study 2022 · repeated low-dose caffeine during total sleep deprivation · young recreational runners who were non-habitual caffeine users, undergoing total sleep deprivation | 6 mg/kg | 1 day | — |
| Effects of Caffeine on Durability After a Simulated Race in Trained Cyclists: A Field-Based Cross-Over Randomized Controlled Trial 2026 · caffeine condition · Well-trained junior cyclists, mean age 16.3 ± 0.5 years | 6 mg/kg | 1 day | — |
| The effects of caffeine on simulated night-shift work and subsequent daytime sleep 1995 · caffeine group · healthy volunteers | 4 mg/kg | 3 days | — |
| Caffeine effects on learning, performance, and anxiety in normal school-age children 1994 · 2.5 mg/kg caffeine · Normal prepubertal school-age children | 2.5 mg/kg | 1 day | — |
| Caffeine effects on learning, performance, and anxiety in normal school-age children 1994 · 5.0 mg/kg caffeine · Normal prepubertal school-age children | 5 mg/kg | 1 day | — |
| Decrease of histamine induced bronchoconstriction by caffeine in mild asthma 1993 · caffeine · patients with mild stable asthma; age and sex not reported | 5 mg/kg | 1 day | — |
| Caffeine and the common cold 1997 · caffeinated coffee · Volunteers, including subjects who developed a common cold; the text does not specify age or sex | 1.5 mg/kg | 1 day | — |
| Mood and psychomotor performance effects of the first, but not of subsequent, cup-of-coffee equivalent doses of caffeine consumed after overnight caffeine abstinence 1998 · CPP · Moderate caffeine consumers who abstained from caffeine overnight; age and sex not reported | 1.2 mg/kg | 1 day | — |
| Mood and psychomotor performance effects of the first, but not of subsequent, cup-of-coffee equivalent doses of caffeine consumed after overnight caffeine abstinence 1998 · CCP · Moderate caffeine consumers who abstained from caffeine overnight; age and sex not reported | 2.4 mg/kg | 1 day | — |
| Mood and psychomotor performance effects of the first, but not of subsequent, cup-of-coffee equivalent doses of caffeine consumed after overnight caffeine abstinence 1998 · CCC · Moderate caffeine consumers who abstained from caffeine overnight; age and sex not reported | 3.6 mg/kg | 1 day | — |
| Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption 2004 · 300 mg/day regular caffeine condition · Healthy adult men and women; ages not reported | 300 mg | 5 days | 97 |
| Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: should we consider monitoring central blood pressure? 2005 · Regular coffee · Healthy volunteers, mean age 29 years; eight females and eight males | 80 mg | 1 day | 16 |
| Comparison of the effects of energy drink versus caffeine supplementation on indices of 24-hour ambulatory blood pressure 2012 · Caffeine control · Healthy, nonsmoking, normotensive volunteers aged 18–45 years | 320 mg | 1 day | 9 |
| Effects of coffee on ambulatory blood pressure in older men and women: A randomized controlled trial 1999 · Instant coffee group · Older men and women, mean age 72.1 years (range 54–89), including normotensive and hypertensive participants | 300 mg | 2 weeks | — |
| Randomized Controlled Trial of High-Volume Energy Drink Versus Caffeine Consumption on ECG and Hemodynamic Parameters 2017 · Energy drink · Healthy adults aged 18–40 years, men and women, with no stated diagnosed condition | 320 mg | 1 day | 18 |
| The Effect of a Multi-Ingredient Pre-Workout Supplement on Time to Fatigue in NCAA Division I Cross-Country Athletes 2021 · MIPS-PE condition · NCAA Division I cross-country athletes, male and female, aged about 20 years, without the cardiovascular, pulmonary, or metabolic diseases listed as exclusions | 217 mg | 1 day | 11 |
| The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans 1993 · ephedrine/caffeine combination · Reduced obese patients; age and sex not specified | 600 mg | 24 weeks | 127 |
| Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture 1993 · ephedrine/caffeine compound, open trial · obese patients | 600 mg | 24 weeks | 99 |
| Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial 2002 · herbal treatment · Adults with obesity; mean BMI 31.8 ± 4.1 kg/m² | 192 mg | 26 weeks | 83 |
| Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice 1994 · ephedrine/caffeine (EC) group · Adults with obesity, 20–80% overweight | 600 mg | 15 weeks | 50 |
| Caffeine and 3-km cycling performance: Effects of mouth rinsing, genotype, and time of day 2016 · Ingestion+Rinse · 38 recreational cyclists; age and sex not stated | 6 mg/kg | 1 day | 38 |
| An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial 2001 · active Ma Huang/Guarana · Overweight men and women with BMI ≥29 and ≤35 kg/m² | 240 mg | 8 weeks | 35 |
| Effect of isolated and combined ingestion of caffeine and citrulline malate on resistance exercise and jumping performance: a randomized double-blind placebo-controlled crossover study 2023 · Caffeine and CitMal · Healthy resistance-trained males and females aged 18–45 years, with at least 12 months of resistance training experience and no known medical condition | 5 mg/kg | 1 day | 35 |
| Acute effects of energy drink consumption on microvascular reactivity in young male volunteers at rest: a randomized trial 2024 · Energy drink · Healthy men aged 18–35 years | 80 mg | 1 day | 32 |
| Effects of Carbohydrate Combined with Caffeine on the Sports Performance of Basketball Players 2026 · CH + CAF group · Male college basketball players aged 18–25 years, without chronic disease | 3 mg/kg | 1 day | 32 |
| Acute Co-Ingestion of Caffeine and Sodium Bicarbonate on Muscular Endurance Performance 2024 · sodium bicarbonate combined with caffeine (NaHCO3 + CAF) · Resistance-trained males and females aged 18–35 years | 3 mg/kg | 1 day | 28 |
| Attentional and working memory performance following alcohol and energy drink: A randomised, double-blind, placebo-controlled, factorial design laboratory study 2019 · AMED · Healthy adults aged 18–40, regular caffeine and alcohol consumers | 80 mg | 1 day | 24 |
| The effects of TeaCrine® and caffeine on endurance and cognitive performance during a simulated match in high-level soccer players 2019 · TeaCrine® + caffeine (TCr + Caf) · Male and female Division I and professional soccer players, highly trained and participating in soccer-related activities at least 5 days per week | 150 mg | 1 day | 24 |
| Acute Effect of Caffeine-Based Multi-Ingredient Supplement on Reactive Agility and Jump Height in Recreational Handball Players 2022 · caffeine and guarana (CAF + GUA) · Recreationally trained male handball players; mean age 23.8 ± 1.4 years; healthy | 200 mg | 1 day | 24 |
| [A randomized comparison of two weight-reducing diets. Calorie counting versus low-fat carbohydrate-rich ad libitum diet] 1998 · Seventeen-week conventional hypocaloric high-protein diet group · Obese patients; age and sex not specified | 600 mg | 17 weeks | 22 |
| [A randomized comparison of two weight-reducing diets. Calorie counting versus low-fat carbohydrate-rich ad libitum diet] 1998 · Eight-week low energy diet group · Obese patients; age and sex not specified | 600 mg | 8 weeks | 21 |
| Effects of acute caffeine, theanine and tyrosine supplementation on mental and physical performance in athletes 2019 · SUP (supplement condition) · Male athletes aged 18–25 years; healthy and disease-free, current or former collegiate athletes, and regular caffeine consumers | 1 mg/kg | 1 day | 20 |
| Does Single or Combined Caffeine and Taurine Supplementation Improve Athletic and Cognitive Performance without Affecting Fatigue Level in Elite Boxers? A Double-Blind, Placebo-Controlled Study 2022 · caffeine and taurine (CAF*TAU) · Elite male boxers; mean age 22.14 ± 1.42 years | 6 mg/kg | 1 day | 20 |
| Caffeine and Beetroot Juice Optimize 1,000-m Performance: Shapley Additive Explanations Analysis 2025 · BJ + CAF group · Healthy male undergraduate students, approximately 22 years old, without a stated medical condition | 6 mg/kg | 1 day | 20 |
| Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents 2000 · Caffeine/ephedrine (CE) group · Obese adolescents aged approximately 14.2–17.7 years | 300 mg | 20 weeks | 16 |
| Caffeine antagonism of alcohol-induced driving impairment 2001 · 200 mg caffeine plus 0.6 g/kg ethanol · Adults; age and health condition not reported | 200 mg | 1 day | 15 |
| Caffeine antagonism of alcohol-induced driving impairment 2001 · 400 mg caffeine plus 0.6 g/kg ethanol · Adults; age and health condition not reported | 400 mg | 1 day | 15 |
| Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial 2016 · GH + Caf 25 · Japanese men and women aged 20–65 years with BMI 24–30 kg/m² and serum triglycerides 100–250 mg/dL | 25 mg | 12 weeks | 15 |
| Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial 2016 · GH + Caf 50 · Japanese men and women aged 20–65 years with BMI 24–30 kg/m² and serum triglycerides 100–250 mg/dL | 50 mg | 12 weeks | 15 |
| Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial 2016 · GH + Caf 75 · Japanese men and women aged 20–65 years with BMI 24–30 kg/m² and serum triglycerides 100–250 mg/dL | 75 mg | 12 weeks | 15 |
| Effects of dietary nitrate, caffeine, and their combination on 20-km cycling time trial performance 2015 · nitrate plus caffeine · Competitive female cyclists, mean age 31 ± 7 years | 5 mg/kg | 1 day | 14 |
| Effects of ephedrine, caffeine, and their combination on muscular endurance 2003 · Caffeine and ephedrine (C+E) · 13 male subjects; age and health condition not stated | 4 mg/kg | 1 day | 13 |
| The impact of prior coffee consumption on the subsequent ergogenic effect of anhydrous caffeine 2004 · COF (1.1 mg/kg caffeine) + CAF (5 mg/kg) (C) · 13 subjects; age, sex and health status not specified | 6.1 mg/kg | — | 13 |
| The impact of prior coffee consumption on the subsequent ergogenic effect of anhydrous caffeine 2004 · COF + CAF (3 mg/kg) (D) · 13 subjects; age, sex and health status not specified | 4.1 mg/kg | — | 13 |
| The impact of prior coffee consumption on the subsequent ergogenic effect of anhydrous caffeine 2004 · COF + CAF (7 mg/kg) (E) · 13 subjects; age, sex and health status not specified | 8.1 mg/kg | — | 13 |
| Evaluating the effects of caffeine and sodium bicarbonate, ingested individually or in combination, and a taste-matched placebo on high-intensity cycling capacity in healthy males 2016 · BIC-CAF · Healthy, noncycling-trained males; mean age 21 ± 3 years | 5 mg/kg | 1 day | 13 |
| Reducing the dose of combined caffeine and ephedrine preserves the ergogenic effect 2000 · CLE · 12 healthy untrained men | 5 mg/kg | 1 day | 12 |
| Reducing the dose of combined caffeine and ephedrine preserves the ergogenic effect 2000 · LCE · 12 healthy untrained men | 4 mg/kg | 1 day | 12 |
| Caffeine withdrawal and high-intensity endurance cycling performance 2011 · caffeine-caffeine condition · Well-trained, familiarised male cyclists who were habitual caffeine consumers | 4.5 mg/kg | 5 days | 12 |
| The effects of supplementation with P-Synephrine alone and in combination with caffeine on resistance exercise performance 2015 · p-synephrine plus caffeine treatment (SCF) · Healthy college-aged men, approximately 20–26 years old, with resistance-training experience | 100 mg | 4 days | 12 |
| Fatigue related impairments in oculomotor control are prevented by caffeine 2016 · caffeine treatment · Well-trained cyclists aged 20–31 years, 6 male and 6 female; no diagnosed condition stated | 5 mg/kg | 1 day | 12 |
| Fatigue-related impairments in oculomotor control are prevented by norepinephrine-dopamine reuptake inhibition 2017 · Caffeine treatment · Healthy volunteers, 20–48 years, 7 women and 5 men | 7.5 mg/kg | 1 day | 12 |
| Effects of the Combined Supplementation of Caffeine and Rhodiola Rosea with Resistance Training on Lower Limb Explosive Power in Male Volleyball Players 2025 · Combined Group (RHO + CAF) · Male volleyball athletes aged 18–23 years, Chinese first-class athletes with at least two years of professional training experience | 3 mg/kg | 4 weeks | 12 |
| Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use 2003 · caffeine-replete condition · healthy caffeine consumers; age and sex not specified | 400 mg | 7 days | 11 |
| Effects of sodium phosphate and caffeine ingestion on repeated-sprint ability in male athletes 2016 · SP+C · Male team-sport athletes | 6 mg/kg | 6 days | 11 |
| Guarana (Paullinia cupana) but Not Low-Dose Caffeine Improves Cycling Time-Trial Performance Versus Placebo 2024 · guarana (GUA) · Endurance-trained adults, including cyclists and noncyclists; age and sex not reported | 130 mg | 1 day | 11 |
| Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans 1999 · green tea extract · 10 healthy men | 150 mg | 1 day | 10 |
| Opposite actions of caffeine and creatine on muscle relaxation time in humans 2002 · Cr+Caf · healthy male volunteers | 5 mg/kg | 4 days | 10 |
| Caffeine does not alter RPE or pain perception during intense exercise in active women 2012 · caffeine · Active women, mean age 22.1 years | 6 mg/kg | 1 day | 10 |
| Effect of repeated caffeine ingestion on repeated exhaustive exercise endurance 2003 · Trial A: caffeine in the AM and PM · Nine male caffeine users | 2.5 mg/kg | — | 9 |
| Effects of Creatine and Caffeine Supplementation During Resistance Training on Body Composition, Strength, Endurance, Rating of Perceived Exertion and Fatigue in Trained Young Adults 2022 · CR-CAF (creatine and caffeine) · Trained young adults; mean age 22 ± 4 years; sex not specified | 3 mg/kg | 6 weeks | 9 |
| Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure 2005 · caffeine/ephedra trial · Healthy adults, four males and four females; mean age 23.4 years; moderate caffeine users | 150 mg | 1 day | 8 |
| A Combination of Amino Acids and Caffeine Enhances Sprint Running Capacity in a Hot, Hypoxic Environment 2016 · caffeine + EAA · Subelite male team sport athletes | 3 mg/kg | 1 day | 8 |
| Caffeine and sodium bicarbonate supplementation alone or together improve karate performance 2019 · CAF + NaHCO3 · Karatekas aged 20.5 ± 2.4 years; sex not specified; experienced competitive karate athletes | 6,000 mg/kg | 4 days | 8 |
| The Effect of Pre-Exercise Caffeine and Glucose Ingestion on Endurance Capacity in Hypoxia: A Double-Blind Crossover Trial 2024 · caffeine and glucose (Caff−CHO) · Healthy, active, recreationally trained collegiate males, mean age 21.9 years | 6 mg/kg | 1 day | 8 |
| The Effects of Caffeine, Taurine, or Caffeine-Taurine Coingestion on Repeat-Sprint Cycling Performance and Physiological Responses 2017 · C + T (caffeine and taurine) · Seven male team-sport players | 5 mg/kg | 1 day | 7 |
| The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans 2000 · Herbal dietary supplement · Obese females; mean age 41 ± 4 years | 10 mg | 1 day | 6 |
| Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females 2014 · EC · Premenopausal women aged 25–52 with morbid obesity (BMI ≥40 kg/m²) awaiting bariatric surgery | 30 mg | 4 weeks | 6 |
| Combined caffeine and carbohydrate ingestion: effects on nocturnal sleep and exercise performance in athletes 2014 · Caffeine condition · Male cyclists/triathletes, mean age 27.5 years | 6 mg/kg | 1 day | 6 |
| Effects of caffeine on performance and mood depend on the level of caffeine abstinence 2002 · 1 mg/kg caffeine at breakfast, followed by 1 mg/kg caffeine · Moderate caffeine consumers who were caffeine-deprived at testing; age and sex not reported | 2 mg/kg | 1 day | — |
| Effects of caffeine on performance and mood depend on the level of caffeine abstinence 2002 · 2 mg/kg caffeine at breakfast, followed by 1 mg/kg caffeine · Moderate caffeine consumers who were caffeine-deprived at testing; age and sex not reported | 3 mg/kg | 1 day | — |
| The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial 1992 · ephedrine/caffeine combination · Obese patients | 600 mg | 24 weeks | — |
| Reinforcing effects of caffeine and theobromine as found in chocolate 2005 · Methylxanthine-containing capsule group · Participants with no stated age range, sex, or condition | 19 mg | 6 days | — |
| Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation 2005 · green tea-caffeine mixture · Overweight and moderately obese adults after body weight loss; matched for sex, age, BMI, height, body mass, and habitual caffeine intake | 150 mg | 90 days | — |
| Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men 2005 · 90 mg EGCG mixture · men; age and health condition not stated | 600 mg | 1 day | — |
| Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men 2005 · 200 mg EGCG mixture · men; age and health condition not stated | 600 mg | 1 day | — |
| Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men 2005 · 300 mg EGCG mixture · men; age and health condition not stated | 600 mg | 1 day | — |
| Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men 2005 · 400 mg EGCG mixture · men; age and health condition not stated | 600 mg | 1 day | — |
| Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss 2009 · adequate-protein diet plus green tea-caffeine mixture · Overweight and moderately obese adults, mean age 44 years, following weight loss | 150 mg | 90 days | — |
| Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss 2009 · high-protein diet plus green tea-caffeine mixture · Overweight and moderately obese adults, mean age 44 years, following weight loss | 150 mg | 90 days | — |
| The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness 2010 · L-theanine and caffeine combination · Young adults; sex and age range not reported | 40 mg | 1 day | — |
| Effects of caffeine and alcohol on mood and performance changes following consumption of lager 2013 · 4.3% alcohol, 62.5 mg caffeine per drink · Young adults aged 18–30 years; male and female; no specific condition stated | 188 mg | 1 day | — |
| Effects of caffeine and alcohol on mood and performance changes following consumption of lager 2013 · 4.3% alcohol, 125 mg caffeine per drink · Young adults aged 18–30 years; male and female; no specific condition stated | 375 mg | 1 day | — |
| The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss 2013 · caffeine/ephedrine (CE) · Obese subjects; age and sex not reported | 600 mg | 24 weeks | — |
| The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss 2013 · leptin A-200 plus caffeine/ephedrine (LCE) · Obese subjects; age and sex not reported | 600 mg | 24 weeks | — |
| Preexercise energy drink consumption does not improve endurance cycling performance but increases lactate, monocyte, and interleukin-6 response 2014 · energy drink (ED) · Trained male cyclists; mean age 33.4 years; condition not stated | 160 mg | 1 day | — |
| Consumption of a Coffee Rich in Phenolic Compounds May Improve the Body Composition of People with Overweight or Obesity: Preliminary Insights from a Randomized, Controlled and Blind Crossover Study 2024 · Lightly roasted coffee (LRC) · Adults aged 18–65 with overweight or obesity (BMI 25.0–35.0 kg/m²) | 390 mg | 12 weeks | — |
| Consumption of a Coffee Rich in Phenolic Compounds May Improve the Body Composition of People with Overweight or Obesity: Preliminary Insights from a Randomized, Controlled and Blind Crossover Study 2024 · Commercial roasted coffee (RC) · Adults aged 18–65 with overweight or obesity (BMI 25.0–35.0 kg/m²) | 210 mg | 12 weeks | — |
| Matcha Does Not Affect Electroencephalography during Sleep but May Enhance Mental Well-Being: A Randomized Placebo-Controlled Clinical Trial 2024 · matcha group · Healthy Japanese men and women aged 20 years or older who experienced difficulty sleeping | 71.5 mg | 4 weeks | — |
| Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture 1993 · ephedrine/caffeine combination · obese patients receiving a 4.2 MJ/day diet | 600 mg | 24 weeks | — |
| The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain 1996 · ephedrine plus caffeine group · Heavy smokers who wanted to quit smoking without gaining weight; ages and sex not reported | 600 mg | 39 weeks | — |
| Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake 1997 · Rapid initial weight-loss group · Obese adults aged not reported, mostly women, with BMI 27–40 who were otherwise healthy | 600 mg | 8 weeks | — |
| Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake 1997 · Conventional initial weight-loss group · Obese adults aged not reported, mostly women, with BMI 27–40 who were otherwise healthy | 600 mg | 17 weeks | — |
| Genetic determinants of blood pressure responses to caffeine drinking 2012 · caf · healthy male habitual moderate coffee drinkers | 3 mg/kg | 1 day | 110 |
| Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption 2004 · 600 mg/day regular caffeine condition · Healthy adult men and women; ages not reported | 600 mg | 5 days | 97 |
| Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption 2004 · 250 mg caffeine challenge · Healthy adult men and women; ages not reported | 500 mg | 1 day | 97 |
| The influence of user status and anxious disposition on the hypertensive effects of caffeine 1990 · caffeine · Normotensive subjects; age and sex distribution not reported | 6 mg/kg | 1 day | 60 |
| Caffeine raises blood pressure at work 1998 · 500 mg caffeine · Healthy, nonsmoking, habitual coffee drinkers; age and sex not reported | 500 mg | 2 days | 21 |
| Blood pressure response to the "second cup of coffee" 1990 · caffeine · young male coffee-drinkers | 450 mg | 8 days | 20 |
| Acute effect of caffeine intake on hemodynamics after resistance exercise in young non-hypertensive subjects 2014 · caffeine condition · Young non-hypertensive adults | 4 mg/kg | 1 day | 15 |
| Relationship of blood pressure, behavioral mood state, and physical activity following caffeine ingestion in younger and older women 2009 · Caffeine ingestion, younger women · Healthy women aged 18–22 years who were moderate caffeine consumers | 5 mg/kg | 1 day | 10 |
| Relationship of blood pressure, behavioral mood state, and physical activity following caffeine ingestion in younger and older women 2009 · Caffeine ingestion, older women · Healthy women aged 50–67 years who were moderate caffeine consumers | 5 mg/kg | 1 day | 10 |
| Caffeine tolerance is incomplete: persistent blood pressure responses in the ambulatory setting 2005 · placebo-caffeine (P-C) week · Healthy, nonobese adults aged 21–35 years with normotensive blood pressure who regularly consumed caffeine | 750 mg | 7 days | — |
| A prospective placebo controlled randomized study of caffeine in patients with supraventricular tachycardia undergoing electrophysiologic testing 2015 · caffeine · Adults with symptomatic supraventricular tachycardia undergoing electrophysiologic testing before catheter ablation | 5 mg/kg | 1 day | — |
| Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults 2016 · Arm A: hot coffee consumed over 20 min · Healthy adults aged 18–30 years, men and women, without major or chronic illness | 160 mg | 1 day | 22 |
| Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults 2016 · Arm B: cold coffee consumed over 2 min · Healthy adults aged 18–30 years, men and women, without major or chronic illness | 160 mg | 1 day | 22 |
| Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults 2016 · Arm C: cold coffee consumed over 20 min · Healthy adults aged 18–30 years, men and women, without major or chronic illness | 160 mg | 1 day | 22 |
| Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults 2016 · Arm D: sugar-free energy drink consumed over 2 min · Healthy adults aged 18–30 years, men and women, without major or chronic illness | 160 mg | 1 day | 22 |
| Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults 2016 · Arm E: sugar-free energy drink consumed over 20 min · Healthy adults aged 18–30 years, men and women, without major or chronic illness | 160 mg | 1 day | 22 |
| Comparative Bioavailability and Benefits on Mental Functions of Novel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules: An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study 2024 · SR-Caffeine · Healthy subjects; age and sex not specified | 200 mg | 1 day | 15 |
| Comparative Bioavailability and Benefits on Mental Functions of Novel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules: An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study 2024 · IR-Caffeine · Healthy subjects; age and sex not specified | 200 mg | 1 day | 15 |
| The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers 2002 · 100 mg gum · Healthy, non-smoking adult males | 100 mg | 1 day | 12 |
| The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers 2002 · 200 mg gum · Healthy, non-smoking adult males | 200 mg | 1 day | 12 |
| The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers 2002 · 100 mg capsule · Healthy, non-smoking adult males | 100 mg | 1 day | 12 |
| The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers 2002 · 200 mg capsule · Healthy, non-smoking adult males | 200 mg | 1 day | 12 |
| In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system 2004 · Uncoated immediate-release tablets · 12 healthy male volunteers | 200 mg | 1 day | 12 |
| In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system 2004 · Coated pellets with pH-dependent rapid release · 12 healthy male volunteers | 200 mg | 1 day | 12 |
| In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system 2004 · Pellets with pH- and time-based release · 12 healthy male volunteers | 200 mg | 1 day | 12 |
| Pharmacokinetics of Caffeine in the Lens Capsule/Epithelium After Peroral Intake: A Pilot Randomized Controlled Study 2018 · 120-mg group · Bilateral cataract patients scheduled for cataract surgery | 120 mg | 1 day | 9 |
| Pharmacokinetics of Caffeine in the Lens Capsule/Epithelium After Peroral Intake: A Pilot Randomized Controlled Study 2018 · 180-mg group · Bilateral cataract patients scheduled for cataract surgery | 180 mg | 1 day | 9 |
| Cognitive and Mood Effects of a Nutrient Enriched Breakfast Bar in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled, Parallel Groups Study 2017 · nutrient enriched · Healthy adults aged 21–40 years | 21.5 mg | 8 weeks | 48 |
| Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males 2017 · PWS · Apparently healthy, resistance-trained males; mean age about 21 years | 284 mg | 8 weeks | 27 |
| Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males 2017 · PWS + S · Apparently healthy, resistance-trained males; mean age about 22 years | 284 mg | 8 weeks | 26 |
| Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance 2017 · PWS · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years | 284 mg | 1 day | 25 |
| Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance 2017 · PWS + S · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years | 284 mg | 1 day | 25 |
| Short-Term Effects of a Ready-to-Drink Pre-Workout Beverage on Exercise Performance and Recovery 2017 · RTD · Recreationally active men and women aged 18–40 years with at least six months of resistance-training experience | 200 mg | 7 days | 25 |
| Acute Effect of Caffeine-Based Multi-Ingredient Supplement on Reactive Agility and Jump Height in Recreational Handball Players 2022 · multi-ingredient supplement (MS) · Recreationally trained male handball players; mean age 23.8 ± 1.4 years; healthy | 200 mg | 1 day | 24 |
| Acute Ingestion of a Mixed Flavonoid and Caffeine Supplement Increases Energy Expenditure and Fat Oxidation in Adult Women: A Randomized, Crossover Clinical Trial 2019 · Mixed flavonoid-caffeine (MFC) supplement · Healthy premenopausal women aged 20–47 years | 214 mg | 1 day | 19 |
| Effects of intake of a mixture of thiamin, arginine, caffeine, and citric acid on adiposity in healthy subjects with high percent body fat 2003 · TACC-supplemented tea · Healthy subjects with body fat percentage ≥25%; ages and sex not reported | 52 mg | 12 weeks | 16 |
| Improved cycling time-trial performance after ingestion of a caffeine energy drink 2009 · Red Bull Energy Drink · Trained male and female cyclists; mean age 27.3 years | 160 mg | 1 day | 12 |
| Acute effectiveness of a "fat-loss" product on substrate utilization, perception of hunger, mood state and rate of perceived exertion at rest and during exercise 2015 · SHRED · Healthy recreationally active adults, 24 ± 3.8 years old; five women and seven men | 50 mg | 1 day | 12 |
| Twelve weeks supplementation with an extended-release caffeine and ATP-enhancing supplement may improve body composition without affecting hematology in resistance-trained men 2016 · TRT · Healthy resistance-trained men; mean age 27.2 ± 5.6 years | 129 mg | 12 weeks | 10 |
| Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease 2011 · caffeine, patients with CAD · Adults with documented stable coronary artery disease; age and gender matched to controls | 200 mg | 1 day | 40 |
| Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease 2011 · caffeine, controls without CAD · Adults without coronary artery disease, age and gender matched to patients with CAD | 200 mg | 1 day | 40 |
| Acute caffeine administration effect on brain activation patterns in mild cognitive impairment 2014 · caffeine · 17 individuals with mild cognitive impairment and 17 age-matched healthy controls; regular caffeine consumers | 200 mg | 1 day | 34 |
| Large Intra-subject Variability in Caffeine Pharmacokinetics: Randomized Cross-over Study of Single Caffeine Product 2017 · 200 mg caffeine (overt or covert presentation) · Healthy adults; mean age 33.3 years; 6% female | 200 mg | 1 day | 32 |
| The effect of caffeine on cutaneous postocclusive reactive hyperaemia 2019 · caffeine · Young, healthy adult volunteers, 14 men and 18 women; mean age 25.2 years | 200 mg | 1 day | 32 |
| The acute effects of thermogenic fitness drink formulas containing 140 mg and 100 mg of caffeine on energy expenditure and fat metabolism at rest and during exercise 2020 · 140 mg formula · Recreationally active men and women aged 18–35 years who regularly consumed no more than 250 mg caffeine per day | 140 mg | 1 day | 32 |
| The acute effects of thermogenic fitness drink formulas containing 140 mg and 100 mg of caffeine on energy expenditure and fat metabolism at rest and during exercise 2020 · 100 mg formula · Recreationally active men and women aged 18–35 years who regularly consumed no more than 250 mg caffeine per day | 100 mg | 1 day | 32 |
| Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A 2009 · Caffeine administered individually · Healthy male subjects; age not reported; poor metabolizers of CYP2C9, CYP2C19 and CYP2D6 excluded | 100 mg | 1 day | 30 |
| Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A 2009 · Five-probe cocktail treatment · Healthy male subjects; age not reported; poor metabolizers of CYP2C9, CYP2C19 and CYP2D6 excluded | 100 mg | 1 day | 30 |
| Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover Study 2015 · Cooperstown cocktail alone · Healthy men and nonpregnant, nonlactating women aged 18–45 years | 200 mg | 1 day | 30 |
| Effects of caffeine on glucose tolerance: a placebo-controlled study 1998 · caffeine · Healthy nonsmoking adults aged 26–32 years who abstained from coffee, tea, chocolate and cola | 200 mg | 1 day | 30 |
| Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover Study 2015 · Cooperstown cocktail plus LDX · Healthy men and nonpregnant, nonlactating women aged 18–45 years | 200 mg | 1 day | 29 |
| Alteration of Resting Electroencephalography by Acute Caffeine Consumption in Early Phase Psychosis 2022 · caffeine session · Adults aged 19–38, including healthy controls aged 19–35 and people aged 21–38 diagnosed with schizophrenia within the previous 5 years | 200 mg | 1 day | 27 |
| Dose effect of caffeine on testosterone and cortisol responses to resistance exercise 2008 · 200 mg caffeine · Professional rugby-league players; age and sex not stated | 200 mg | 1 day | 24 |
| Black tea is not significantly different from water in the maintenance of normal hydration in human subjects: results from a randomised controlled trial 2011 · 4 × 240 ml black tea · Healthy resting males recruited from the general population; mean age 36 years | 168 mg | 1 day | 21 |
| Impact of Beta-Alanine, Caffeine, and Their Combination on Intraocular Pressure and Ocular Perfusion Pressure at Rest and After Resistance Training 2025 · caffeine · Young men, mean age 23.4 ± 4.5 years; no condition stated | 200 mg | 1 day | 20 |
| The effect of caffeine on choroidal thickness in young healthy subjects 2015 · study group · otherwise healthy caffeine users | 200 mg | 1 day | 18 |
| Effect of caffeine on superficial retinal vasculature of the macula in high myopes using optical coherence tomography angiography - A pilot study 2022 · caffeine visit · Healthy high myopes aged 20–29 years, male and female, without ocular or systemic disease | 200 mg | 1 day | 18 |
| Habitual preexercise caffeine supplementation prevents exercise training-induced attenuation of exercising systolic blood pressure and double product 2025 · caffeine supplement group (CAF) · Women aged 18–45 years, otherwise healthy, with habitual caffeine consumption ≤200 mg/day or after caffeine washout | 120 mg | 6 weeks | 17 |
| Pharmacokinetic Profile of Caffeine and Its Two Main Metabolites in Dried Blood Spots After Five Different Oral Caffeine Administration Forms-A Randomized Crossover Study 2024 · caffeinated capsules · Healthy recreational athletes, mean age 26.0 ± 2.1 years | 200 mg | 1 day | 16 |
| Pharmacokinetic Profile of Caffeine and Its Two Main Metabolites in Dried Blood Spots After Five Different Oral Caffeine Administration Forms-A Randomized Crossover Study 2024 · caffeinated tablets · Healthy recreational athletes, mean age 26.0 ± 2.1 years | 200 mg | 1 day | 16 |
| Pharmacokinetic Profile of Caffeine and Its Two Main Metabolites in Dried Blood Spots After Five Different Oral Caffeine Administration Forms-A Randomized Crossover Study 2024 · caffeinated shots · Healthy recreational athletes, mean age 26.0 ± 2.1 years | 200 mg | 1 day | 16 |
| Pharmacokinetic Profile of Caffeine and Its Two Main Metabolites in Dried Blood Spots After Five Different Oral Caffeine Administration Forms-A Randomized Crossover Study 2024 · caffeinated pouches · Healthy recreational athletes, mean age 26.0 ± 2.1 years | 200 mg | 1 day | 16 |
| Pharmacokinetic Profile of Caffeine and Its Two Main Metabolites in Dried Blood Spots After Five Different Oral Caffeine Administration Forms-A Randomized Crossover Study 2024 · caffeinated chewing gums · Healthy recreational athletes, mean age 26.0 ± 2.1 years | 200 mg | 1 day | 16 |
| Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes 1997 · Caffeine administered individually · Healthy nonsmoking men; mean age 21.6 years (SD 2.2) | 100 mg | 1 day | 14 |
| Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes 1997 · Caffeine in four-drug combination · Healthy nonsmoking men; mean age 21.6 years (SD 2.2) | 100 mg | 1 day | 14 |
| Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes 1997 · Caffeine in five-drug combination · Healthy nonsmoking men; mean age 21.6 years (SD 2.2) | 100 mg | 1 day | 14 |
| Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2 1999 · Caffeine study periods (with and without pefloxacin or enoxacin) · 12 healthy young volunteers | 183 mg | — | 12 |
| Pantoprazole lacks induction of CYP1A2 activity in man 1999 · Caffeine administration during both treatment periods · 12 healthy, non-smoking volunteers; age and sex not reported | 200 mg | 2 days | 12 |
| Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2 2002 · Caffeine challenge (all participants) · Healthy extensive metabolizers with respect to CYP2C19; six with CYP1A2*1F/CYP1A2*1F and six with CYP1A2*1C/CYP1A2*1F | 200 mg | 16 days | 12 |
| Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450(CYP)1A2 2003 · caffeine · 12 healthy individuals; sex and age not reported | 200 mg | 1 day | 12 |
| Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine 1992 · Caffeine · 12 healthy young volunteers | 183 mg | — | 12 |
| Habitual coffee and tea drinkers experienced increases in blood pressure after consuming low to moderate doses of caffeine; these increases were larger upright than in the supine posture 2011 · 133 mg caffeine · Healthy habitual coffee and tea drinkers; 10 of 12 participants were female, mean age 36 | 133 mg | 1 day | 12 |
| Habitual coffee and tea drinkers experienced increases in blood pressure after consuming low to moderate doses of caffeine; these increases were larger upright than in the supine posture 2011 · 200 mg caffeine · Healthy habitual coffee and tea drinkers; 10 of 12 participants were female, mean age 36 | 200 mg | 1 day | 12 |
| Bioavailability of paracetamol with/without caffeine in Egyptian patients with hepatitis C virus 2016 · Healthy subjects treated with Para-Caf · Healthy volunteers | 130 mg | 1 day | 10 |
| Bioavailability of paracetamol with/without caffeine in Egyptian patients with hepatitis C virus 2016 · Hepatic subjects treated with Para-Caf · Adults with genotype-4 HCV and Child-Pugh B liver disease | 130 mg | 1 day | 10 |
| Immune modulation in response to coffee intake: a pilot study 2026 · Caffeine solution · Healthy regular coffee consumers, 20–40 years; 5 women and 5 men overall | 130 mg | 1 day | 10 |
| Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects 2013 · green coffee caffeine powder (N677) · healthy subjects; age and sex not reported | 100 mg | 1 day | — |
| The thermic effect of sugar-free Red Bull: do the non-caffeine bioactive ingredients in energy drinks play a role? 2015 · water + 120 mg caffeine · Eight healthy young men | 120 mg | 1 day | — |
| A single serving of caffeinated coffee impairs postprandial glucose metabolism in overweight men 2015 · 2 g decaffeinated coffee with 100 mg caffeine (first part; caffeine varied with coffee) · Healthy overweight males | 100 mg | 1 day | — |
| A single serving of caffeinated coffee impairs postprandial glucose metabolism in overweight men 2015 · 4 g decaffeinated coffee with 200 mg caffeine (first part; caffeine varied with coffee) · Healthy overweight males | 200 mg | 1 day | — |
| A single serving of caffeinated coffee impairs postprandial glucose metabolism in overweight men 2015 · 2 g decaffeinated coffee with 100 mg caffeine (second part; caffeine held constant) · Healthy overweight males | 100 mg | 1 day | — |
| A single serving of caffeinated coffee impairs postprandial glucose metabolism in overweight men 2015 · 4 g decaffeinated coffee with 100 mg caffeine (second part; caffeine held constant) · Healthy overweight males | 100 mg | 1 day | — |
| A single serving of caffeinated coffee impairs postprandial glucose metabolism in overweight men 2015 · 8 g decaffeinated coffee with 100 mg caffeine (second part; caffeine held constant) · Healthy overweight males | 100 mg | 1 day | — |
| Single high-dose peroral caffeine intake inhibits ultraviolet radiation-induced apoptosis in human lens epithelial cells in vitro 2021 · caffeine intake · Patients planned for cataract surgery of both eyes; age and sex not specified | 180 mg | 1 day | — |
| A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, and Cognitive Performance 2025 · CAF (caffeinated energy drink) · Healthy, recreationally active men and women aged 30–60 years who reported consuming at least 75 mg caffeine per day | 200 mg | 4 weeks | — |
| Cardio- and cerebrovascular responses to the energy drink Red Bull in young adults: a randomized cross-over study 2014 · Red Bull · Healthy adults aged 20–31 years, women and men, without reported cardiovascular disease or medication affecting cardiovascular or autonomic regulation | 114 mg | 1 day | 25 |
| Comparison of the effects of energy drink versus caffeine supplementation on indices of 24-hour ambulatory blood pressure 2012 · Energy drink · Healthy, nonsmoking, normotensive volunteers aged 18–45 years | 320 mg | 1 day | 9 |
| Enhanced stimulant and metabolic effects of combined ephedrine and caffeine 2004 · ephedrine plus caffeine · Healthy adults; age and sex distribution not specified | 200 mg | 1 day | — |
| Caffeine tolerance is incomplete: persistent blood pressure responses in the ambulatory setting 2005 · caffeine low (C300) week · Healthy, nonobese adults aged 21–35 years with normotensive blood pressure who regularly consumed caffeine | 1.05 g | 7 days | — |
| Caffeine tolerance is incomplete: persistent blood pressure responses in the ambulatory setting 2005 · caffeine high (C600) week · Healthy, nonobese adults aged 21–35 years with normotensive blood pressure who regularly consumed caffeine | 1.35 g | 7 days | — |
| Caffeine and blood pressure response: sex, age, and hormonal status 2010 · Caffeine week · Healthy men and women aged 35–64, including premenopausal and postmenopausal women; normotensive | 240 mg | 7 days | — |
| Absorption and subjective effects of caffeine from coffee, cola and capsules 1997 · 400 mg caffeine via unsweetened coffee · Thirteen users of both coffee and cola; mean daily caffeine consumption 456 mg | 400 mg | 1 day | 13 |
| Absorption and subjective effects of caffeine from coffee, cola and capsules 1997 · 400 mg caffeine via sugar-free cola · Thirteen users of both coffee and cola; mean daily caffeine consumption 456 mg | 400 mg | 1 day | 13 |
| Absorption and subjective effects of caffeine from coffee, cola and capsules 1997 · 400 mg caffeine via capsules · Thirteen users of both coffee and cola; mean daily caffeine consumption 456 mg | 400 mg | 1 day | 13 |
| The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers 2002 · 50 mg gum · Healthy, non-smoking adult males | 50 mg | 1 day | 12 |
| The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers 2002 · 50 mg capsule · Healthy, non-smoking adult males | 50 mg | 1 day | 12 |
| Pharmacokinetics of Caffeine in the Lens Capsule/Epithelium After Peroral Intake: A Pilot Randomized Controlled Study 2018 · 60-mg group · Bilateral cataract patients scheduled for cataract surgery | 60 mg | 1 day | 8 |
| A double-blind, randomized, two-part, two-period crossover study to evaluate the pharmacokinetics of caffeine versus d9-caffeine in healthy subjects 2022 · caffeine, 50 mg · healthy adults | 50 mg | 1 day | — |
| A double-blind, randomized, two-part, two-period crossover study to evaluate the pharmacokinetics of caffeine versus d9-caffeine in healthy subjects 2022 · caffeine, 250 mg · healthy adults | 250 mg | 1 day | — |
| Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans 2011 · Experimental treatment product (Acceleron®) · Mildly overweight adult men and women; ages not stated | 704 mg | 1 day | 23 |
| Caffeine effects on resting-state arousal in children 2009 · caffeine · Healthy children aged 8–13 years | 80 mg | 1 day | 30 |
| Caffeine slows heart rate autonomic recovery following strength exercise in healthy subjects 2021 · caffeine protocol · healthy volunteers; age range and sex not stated | 300 mg | 1 day | 30 |
| Caffeine reduces cerebral blood flow in patients recovering from an ischaemic stroke 2004 · caffeine · 19 patients recovering from an acute ischaemic stroke in the middle cerebral artery territory and 10 controls | 250 mg | 1 day | 29 |
| Bioequivalence and Pharmacokinetic Evaluation Study of Acetaminophen vs. Acetaminophen Plus Caffeine Tablets in Healthy Mexican Volunteers 2016 · Test product (acetaminophen plus caffeine; Sedalmerck Max) · Healthy Mexican volunteers aged 18–45 years; five women and 21 men enrolled | 65 mg | 1 day | 26 |
| Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine 2003 · fleroxacin and caffeine regimen · healthy male and female volunteers | 300 mg | 3 days | 24 |
| Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine 2003 · ciprofloxacin and caffeine regimen · healthy male and female volunteers | 300 mg | 3 days | 24 |
| Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine 2003 · caffeine alone · healthy male and female volunteers | 300 mg | 3 days | 24 |
| Dose effect of caffeine on testosterone and cortisol responses to resistance exercise 2008 · 400 mg caffeine · Professional rugby-league players; age and sex not stated | 400 mg | 1 day | 24 |
| Black tea is not significantly different from water in the maintenance of normal hydration in human subjects: results from a randomised controlled trial 2011 · 6 × 240 ml black tea · Healthy resting males recruited from the general population; mean age 36 years | 252 mg | 1 day | 21 |
| Dietary caffeine consumption and withdrawal: confounding variables in quantitative cerebral perfusion studies? 2003 · caffeine · Adults aged 24–64, 16 men and 4 women, categorized as low (mean 41 mg/day) or high (mean 648 mg/day) dietary caffeine users | 250 mg | 1 day | 20 |
| Impact of Beta-Alanine, Caffeine, and Their Combination on Intraocular Pressure and Ocular Perfusion Pressure at Rest and After Resistance Training 2025 · caffeine + beta-alanine · Young men, mean age 23.4 ± 4.5 years; no condition stated | 200 mg | 1 day | 20 |
| Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder 2015 · caffeine-challenge · Patients with panic disorder | 400 mg | 1 day | 19 |
| Repeated caffeine intake suppresses cerebral grey matter responses to chronic sleep restriction in an A(1) adenosine receptor-dependent manner: a double-blind randomized controlled study with PET-MRI 2024 · CAFF group · Healthy adults aged 28.9 ± 5.2 years; non-smokers with habitual caffeine intake below 450 mg | 300 mg | 5 days | 19 |
| Caffeine effects on resting-state arousal 2005 · caffeine · Healthy university students, mean age 21 years; 13 of 18 were female | 250 mg | 1 day | 18 |
| Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial 2007 · caffeine · Healthy adults aged 18 to 22 years with a history of caffeine consumption | 400 mg | 7 days | 16 |
| Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial 2011 · Caffeinated coffee · Overweight, otherwise healthy adult men and women aged 18 years or older who regularly consumed at least 2 cups of coffee daily | 345 mg | 8 weeks | 16 |
| Effects of moderate caffeine intake on the calcium economy of premenopausal women 1990 · caffeine · Healthy premenopausal women | 400 mg | 19 days | 16 |
| Mapping the pharmacological modulation of brain oxygen metabolism: The effects of caffeine on absolute CMRO(2) measured using dual calibrated fMRI 2017 · caffeine · Healthy adults aged 24.7±5.1 years, male and female, who were low-to-moderate caffeine consumers | 250 mg | 1 day | 16 |
| A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil 2025 · Phase II: Geneva cocktail · Healthy volunteers, 23 ± 3 years on average; eight women and eight men | 50 mg | 1 day | 16 |
| A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil 2025 · Phase III: Geneva cocktail + repaglinide · Healthy volunteers, 23 ± 3 years on average; eight women and eight men | 50 mg | 1 day | 16 |
| A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil 2025 · Phase IV: clopidogrel pretreatment followed by Geneva cocktail + repaglinide · Healthy volunteers, 23 ± 3 years on average; eight women and eight men | 50 mg | 1 day | 16 |
| A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil 2025 · Phase V: gemfibrozil pretreatment followed by Geneva cocktail + repaglinide · Healthy volunteers, 23 ± 3 years on average; eight women and eight men | 50 mg | 1 day | 16 |
| Effects of caffeine on heart rate and QT variability during sleep 2005 · caffeine protocol · young adult normal subjects | 400 mg | 1 day | 15 |
| Separating neural and vascular effects of caffeine using simultaneous EEG-FMRI: differential effects of caffeine on cognitive and sensorimotor brain responses 2012 · caffeine · Healthy right-handed men aged 20–32 years who were non- or infrequent caffeine consumers (≤36 mg/day) | 250 mg | 1 day | 14 |
| Oolong tea increases metabolic rate and fat oxidation in men 2001 · Caffeinated water · Men; age and health condition not reported | 270 mg | 3 days | 12 |
| Effects of caffeine on the kinetics of fluvoxamine and its major metabolite in plasma after a single oral dose of the drug 2006 · caffeine · 12 healthy male volunteers | 300 mg | 11 days | 12 |
| Habitual coffee and tea drinkers experienced increases in blood pressure after consuming low to moderate doses of caffeine; these increases were larger upright than in the supine posture 2011 · 67 mg caffeine · Healthy habitual coffee and tea drinkers; 10 of 12 participants were female, mean age 36 | 67 mg | 1 day | 12 |
| The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females 1999 · Caffeine administered during the follicular, ovulatory and luteal phases · 10 healthy, non-smoking, eumenorrheic women who were not pregnant and had not used oral contraceptives for at least 3 months | 300 mg | 1 day | 10 |
| Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics 2005 · Caffeine with fluvoxamine · Seven healthy subjects | 250 mg | 1 day | 7 |
| Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics 2005 · Caffeine with matching placebo · Seven healthy subjects | 250 mg | 1 day | 7 |
| Caffeine intake enhances the benefits of sodium glucose transporter 2 inhibitor 2016 · Caffeine 500 · Patients with type 2 diabetes taking ipragliflozin; age and sex not reported | 400 mg | 1 day | 6 |
| Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers 2001 · caffeine · Healthy volunteers aged 17 years or older; sex not specified | 400 mg | 1 day | — |
| Acute caffeine intake influences central more than peripheral blood pressure in young adults 2003 · caffeine · healthy young adults; sex and age range not specified | 300 mg | 1 day | — |
| The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake 2009 · caffeine · healthy, normal-weight men, mean age 23.7 years | 50 mg | 1 day | — |
| Caffeine in hot drinks elicits cephalic phase responses involving cardiac activity 2012 · Decaffeinated coffee with 67 mg caffeine · Women; age and health condition not stated | 67 mg | 1 day | — |
| A single serving of caffeinated coffee impairs postprandial glucose metabolism in overweight men 2015 · 8 g decaffeinated coffee with 400 mg caffeine (first part; caffeine varied with coffee) · Healthy overweight males | 400 mg | 1 day | — |
| Glucose control upon waking is unaffected by hourly sleep fragmentation during the night, but is impaired by morning caffeinated coffee 2020 · Fragmented + Coffee · Healthy adults, mean age 21 years | 300 mg | 1 day | — |
| A low- dose of caffeine suppresses EEG alpha power and improves working memory in healthy University males 2022 · caffeinated drink (CAF) · Healthy Southeast Asian university men; mean age 21 ± 2 years | 50 mg | 1 day | — |
| Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans 1997 · Dim Light-Caffeine · Humans undergoing 45.5 hours of sleep deprivation; age, sex, and health condition not stated | 400 mg | 2 days | — |
| Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans 1997 · Bright-Light Caffeine · Humans undergoing 45.5 hours of sleep deprivation; age, sex, and health condition not stated | 400 mg | 2 days | — |
| Influence of carbohydrate on serum caffeine concentrations following caffeine ingestion 2013 · 6 mg/kg caffeine, fasted · healthy males | 6 mg/kg | 1 day | 14 |
| Influence of carbohydrate on serum caffeine concentrations following caffeine ingestion 2013 · 9 mg/kg caffeine, fasted · healthy males | 9 mg/kg | 1 day | 14 |
| Influence of carbohydrate on serum caffeine concentrations following caffeine ingestion 2013 · 6 mg/kg caffeine after a high carbohydrate meal · healthy males | 6 mg/kg | 1 day | 14 |
| Influence of carbohydrate on serum caffeine concentrations following caffeine ingestion 2013 · 9 mg/kg caffeine after a high carbohydrate meal · healthy males | 9 mg/kg | 1 day | 14 |
| Caffeine in sport. Influence of endurance exercise on the urinary caffeine concentration 1992 · Caffeine with and without exercise (crossover) · Nine endurance-trained athletes | 450 mg | 1 day | 9 |
| Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity 1996 · 3 mg/kg group · newborn premature infants treated for apnea of prematurity | 3 mg/kg | 7 days | — |
| Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity 1996 · 15 mg/kg group · newborn premature infants treated for apnea of prematurity | 15 mg/kg | 7 days | — |
| Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity 1996 · 30 mg/kg group · newborn premature infants treated for apnea of prematurity | 30 mg/kg | 7 days | — |
| Heart Rate Variability Behavior during Exercise and Short-Term Recovery Following Energy Drink Consumption in Men and Women 2020 · energy drink (ED) · Recreationally active men and women aged 21–25 years who regularly consumed moderate amounts of caffeine | 140 mg | 1 day | 17 |
| Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels 2005 · PC week (placebo maintenance, caffeine challenge) · Healthy, nonobese adults; men and women; ages not specified; no diagnosed condition stated | 750 mg | 7 days | 98 |
| Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women 2006 · Caffeine test week (P–C week) · Healthy normotensive men and women, recruited as adult volunteers; ages not specified | 750 mg | 1 day | 96 |
| Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans 2002 · caffeine capsules · Adults aged 19–65 years; healthy volunteers; men and women | 870 mg | 2 weeks | 48 |
| Caffeine Habituation, Not CYP1A2 Genotype, Modulates the Acute Effect of Caffeine on Exercise-Induced Hemostatic Responses in Adults with Obesity 2025 · caffeine · Physically inactive young men with obesity, age 22.2 ± 2.3 years; caffeine-habituation status varied | 3 mg/kg | 1 day | 40 |
| Gender and body mass index modify the effect of increasing amounts of caffeinated coffee on postprandial glucose and insulin concentrations; a randomized, controlled, clinical trial 2013 · 3 mg caffeine/kg body weight coffee · Healthy adults aged 19–44 years, women and men, normal-weight and overweight/obese | 3 mg/kg | 1 day | 33 |
| Gender and body mass index modify the effect of increasing amounts of caffeinated coffee on postprandial glucose and insulin concentrations; a randomized, controlled, clinical trial 2013 · 6 mg caffeine/kg body weight coffee · Healthy adults aged 19–44 years, women and men, normal-weight and overweight/obese | 6 mg/kg | 1 day | 33 |
| Effect of MCT1 A1470T Polymorphism on Lactate and Potassium Concentrations After Caffeine Ingestion During Acute Resistance Exercise 2024 · caffeine (CAF) · Resistance-trained men, average age 21.72 years; light caffeine consumers, with different MCT1 A1470T genotypes | 6 mg/kg | 1 day | 30 |
| Acute Effects of Caffeine on Heart Rate Variability, Blood Pressure and Tidal Volume in Paraplegic and Tetraplegic Compared to Able-Bodied Individuals: A Randomized, Blinded Trial 2016 · Caffeine trial · Healthy, physically active, non-smoking men aged 18–60, including able-bodied participants and participants with complete paraplegia or tetraplegia; 28 analyzed across the groups | 6 mg/kg | 1 day | 28 |
| Acute Cardiovascular Effects of Turkish Coffee Assessed by VO(2) Test: A Randomized Crossover Trial 2025 · Turkish coffee (TC) · Healthy, non-smoking female university students aged 18–39 years | 3 mg/kg | 1 day | 25 |
| Dose effect of caffeine on testosterone and cortisol responses to resistance exercise 2008 · 800 mg caffeine · Professional rugby-league players; age and sex not stated | 800 mg | 1 day | 24 |
| Caffeine ingestion impairs insulin sensitivity in a dose-dependent manner in both men and women 2013 · 1 mg·kg(-1) caffeine · Healthy adult men and women | 1 mg/kg | 1 day | 24 |
| Caffeine ingestion impairs insulin sensitivity in a dose-dependent manner in both men and women 2013 · 3 mg·kg(-1) caffeine · Healthy adult men and women | 3 mg/kg | 1 day | 24 |
| Caffeine ingestion impairs insulin sensitivity in a dose-dependent manner in both men and women 2013 · 5 mg·kg(-1) caffeine · Healthy adult men and women | 5 mg/kg | 1 day | 24 |
| Caffeine-induced changes in cardiovascular function during resistance training 2007 · caffeine (CAF) · Resistance-trained men | 6 mg/kg | 1 day | 22 |
| Caffeine-Containing Energy Shots Cause Acute Impaired Glucoregulation in Adolescents 2020 · CAF (caffeine-containing energy shot) · Adolescents aged 13–19 years without underlying medical conditions | 5 mg/kg | 1 day | 20 |
| Daily Caffeine Intake Induces Concentration-Dependent Medial Temporal Plasticity in Humans: A Multimodal Double-Blind Randomized Controlled Trial 2021 · caffeine · Habitual caffeine consumers; age and sex not specified | 450 mg | 10 days | 20 |
| Effects of coffee intake on skeletal muscle microvascular reactivity at rest and oxygen extraction during exercise: a randomized cross-over trial 2024 · Low caffeine content coffee (LC) · Healthy, physically active males aged 18–30 who did not regularly consume coffee or other caffeinated beverages | 3 mg/kg | 1 day | 20 |
| Effects of coffee intake on skeletal muscle microvascular reactivity at rest and oxygen extraction during exercise: a randomized cross-over trial 2024 · High caffeine content coffee (HC) · Healthy, physically active males aged 18–30 who did not regularly consume coffee or other caffeinated beverages | 6 mg/kg | 1 day | 20 |
| The effect of caffeine ingestion on neutrophil oxidative burst responses following prolonged cycling 2006 · caffeine (CAF) · Endurance-trained male cyclists; age and health condition not reported | 6 mg/kg | 1 day | 19 |
| Acute caffeine ingestion and glucose tolerance in women with or without gestational diabetes mellitus 2009 · Caffeine, control group · Women whose routine gestational diabetes test was negative | 3 mg/kg | 1 day | 19 |
| Genetic Polymorphisms in ADORA2A and CYP1A2 Influence Caffeine's Effect on Postprandial Glycaemia 2019 · CHO + CAFF · Healthy men aged 18–35 years; free of cardiovascular, metabolic, and neuromuscular disease | 4 mg/kg | 1 day | 18 |
| Effects of caffeine consumption on intraocular pressure during low-intensity endurance exercise: A placebo-controlled, double-blind, balanced crossover study 2020 · caffeine condition · physically active young adults, mean age 23.3 ± 2.4 years | 4 mg/kg | 1 day | 18 |
| Omeprazole weakly inhibits CYP1A2 activity in man 1999 · Caffeine dose following omeprazole or placebo · 16 healthy volunteers: 12 CYP2C19 extensive metabolizers and 4 poor metabolizers | 3 mg/kg | 1 day | 16 |
| Caffeinated coffee does not acutely affect energy intake, appetite, or inflammation but prevents serum cortisol concentrations from falling in healthy men 2011 · caffeinated coffee · Healthy men aged 21–39 years | 3 mg/kg | 1 day | 16 |
| Effects of Bang® Keto Coffee Energy Drink on Metabolism and Exercise Performance in Resistance-Trained Adults: A Randomized, Double-blind, Placebo-controlled, Crossover Study 2020 · Bang® Keto Coffee energy drink · Resistance-trained, generally healthy adults aged 18–40 years; 8 males and 8 females; regular caffeine consumers | 300 mg | 1 day | 16 |
| Effect of a single and repeated dose of caffeine on antigen-stimulated human natural killer cell CD69 expression after high-intensity intermittent exercise 2011 · 3 × CAF · Healthy males | 6 mg/kg | 1 day | 15 |
| Effect of a single and repeated dose of caffeine on antigen-stimulated human natural killer cell CD69 expression after high-intensity intermittent exercise 2011 · 1 × CAF · Healthy males | 6 mg/kg | 1 day | 15 |
| The ADORA2A TT Genotype Is Associated with Anti-Inflammatory Effects of Caffeine in Response to Resistance Exercise and Habitual Coffee Intake 2023 · caffeine condition · resistance-trained Iranian men who were light caffeine consumers; age range and genotype breakdown not stated | 6 mg/kg | 1 day | 15 |
| Caffeine consumption around an exercise bout: effects on energy expenditure, energy intake, and exercise enjoyment 2014 · caffeine exercise trial (EX+CAF) · 14 recreationally active participants; sex and age not reported | 6 mg/kg | 1 day | 14 |
| Caffeine increases sweating sensitivity via changes in sudomotor activity during physical loading 2011 · Caffe-I (caffeine-consuming group) · Athletically trained males, mean age 22.1 years | 3 mg/kg | 1 day | 13 |
| Metabolic response to green tea extract during rest and moderate-intensity exercise 2013 · GTE · Healthy, physically active males | 240 mg | 7 days | 13 |
| Effects of acute caffeine supplementation on reducing exercise-associated hypoglycaemia in individuals with Type 1 diabetes mellitus 2016 · caffeine · Adults with Type 1 diabetes; eight women and five men, mean age 25.9 years | 6 mg/kg | 1 day | 13 |
| Acute caffeine intake increases muscle oxygen saturation during a maximal incremental exercise test 2020 · caffeine · 13 healthy, active individuals | 3 mg/kg | 1 day | 13 |
| Effect of caffeine on clozapine pharmacokinetics in healthy volunteers 2000 · Caffeine phase · Healthy nonsmoking male volunteers | 550 mg | 2 days | 12 |
| The effect of caffeine on glucose kinetics in humans--influence of adrenaline 2005 · caffeine capsules · Human subjects; age, sex, and health condition not stated | 5 mg/kg | 1 day | 12 |
| Effect of a high and low dose of caffeine on antigen-stimulated activation of human natural killer cells after prolonged cycling 2011 · 2CAF · Healthy male endurance-trained cyclists | 2 mg/kg | 1 day | 12 |
| Effect of a high and low dose of caffeine on antigen-stimulated activation of human natural killer cells after prolonged cycling 2011 · 6CAF · Healthy male endurance-trained cyclists | 6 mg/kg | 1 day | 12 |
| Dose effects of caffeine ingestion on acute hormonal responses to resistance exercise 2015 · High dose (HD) · University males who regularly performed resistance exercise; age not stated | 6 mg/kg | 1 day | 12 |
| Dose effects of caffeine ingestion on acute hormonal responses to resistance exercise 2015 · Medium dose (MD) · University males who regularly performed resistance exercise; age not stated | 4 mg/kg | 1 day | 12 |
| Dose effects of caffeine ingestion on acute hormonal responses to resistance exercise 2015 · Low dose (LD) · University males who regularly performed resistance exercise; age not stated | 2 mg/kg | 1 day | 12 |
| Caffeine increases whole-body fat oxidation during 1 h of cycling at Fatmax 2021 · caffeine · 12 healthy participants; age and sex not reported | 3 mg/kg | 1 day | 12 |
| Salivary IgA responses to prolonged intensive exercise following caffeine ingestion 2006 · CAF · Endurance-trained males | 6 mg/kg | 1 day | 11 |
| [1,3,7-trimethylxanthine. Effects on circadian aqueous humor dynamics in probands] 1992 · Group I · Healthy volunteers, ten men and women in total, mean age 27 years | 800 mg | 1 day | 10 |
| Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men 2008 · Caffeinated coffee (high- and low-GI meal trials) · Healthy men; ages not reported | 5 mg/kg | 1 day | 10 |
| Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males 2010 · caffeinated coffee (CC) · healthy young adult males | 5 mg/kg | 1 day | 10 |
| An oral lipid challenge and acute intake of caffeinated coffee additively decrease glucose tolerance in healthy men 2011 · caffeinated coffee trials · young, healthy males | 5 mg/kg | 1 day | 10 |
| Caffeine Augments Sustained Hyperemia in Previously Exercised Leg in Male Competitive Long-Distance Runners 2025 · caffeine condition · male competitive long-distance runners | 6 mg/kg | 1 day | 10 |
| Effects of caffeine on blood pressure, heart rate, and forearm blood flow during dynamic leg exercise 1998 · caffeine · 10 trained, caffeine-naive cyclists (7 women and 3 men) | 6 mg/kg | 1 day | 10 |
| Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss 2004 · caffeine · sedentary obese men | 5 mg/kg | 1 day | 9 |
| Caffeine ingestion and antigen-stimulated human lymphocyte activation after prolonged cycling 2012 · caffeine (CAF) · Nine male endurance cyclists, mean age 22 ± 3 years | 6 mg/kg | 1 day | 9 |
| Dose-dependency of caffeine metabolism with repeated dosing 1990 · low-dose caffeine · Healthy adults; age and sex not reported | 4.2 mg/kg | 5 days | 9 |
| Dose-dependency of caffeine metabolism with repeated dosing 1990 · high-dose caffeine · Healthy adults; age and sex not reported | 12 mg/kg | 5 days | 9 |
| Caffeine's impairment of insulin-mediated glucose disposal cannot be solely attributed to adrenaline in humans 2007 · CAF trial · 8 human subjects; age, sex, and health status not specified | 5 mg/kg | 1 day | 8 |
| Caffeine's impairment of insulin-mediated glucose disposal cannot be solely attributed to adrenaline in humans 2007 · CAF + ADR trial · 8 human subjects; age, sex, and health status not specified | 5 mg/kg | 1 day | 8 |
| Acute caffeine ingestion and glucose tolerance in women with or without gestational diabetes mellitus 2009 · Caffeine, gestational diabetes screen-positive group · Women with an initial positive gestational diabetes screen | 3 mg/kg | 1 day | 8 |
| Caffeine potentiates the renin response to diazoxide in man. Evidence for a regulatory role of endogenous adenosine 1991 · caffeine · Eight normal subjects | 750 mg | 4 days | 8 |
| Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise 2002 · caffeine · Seven men; age and health condition not specified | 5 mg/kg | 1 day | 7 |
| Caffeine during exercise in the heat: thermoregulation and fluid-electrolyte balance 2009 · C(AFF) + NF · Seven endurance-trained, heat-acclimated cyclists; age and sex not reported | 6 mg | 1 day | 7 |
| Caffeine during exercise in the heat: thermoregulation and fluid-electrolyte balance 2009 · C(AFF) + WAT · Seven endurance-trained, heat-acclimated cyclists; age and sex not reported | 6 mg | 1 day | 7 |
| Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness 2000 · low dose · Healthy males aged 18–32 years kept awake for 49 hours before dosing | 2.1 mg/kg | 1 day | — |
| Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness 2000 · medium dose · Healthy males aged 18–32 years kept awake for 49 hours before dosing | 4.3 mg/kg | 1 day | — |
| Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness 2000 · high dose · Healthy males aged 18–32 years kept awake for 49 hours before dosing | 8.6 mg/kg | 1 day | — |
| Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study 2006 · caffeine · Healthy adults aged about 70 years | 6 mg/kg | 1 day | — |
| Effects of different doses of caffeine on exercise responses in young children 2008 · CAF-1 · Healthy boys and girls, described as young children; age range not specified | 1 mg/kg | 1 day | — |
| Effects of different doses of caffeine on exercise responses in young children 2008 · CAF-3 · Healthy boys and girls, described as young children; age range not specified | 3 mg/kg | 1 day | — |
| Effects of different doses of caffeine on exercise responses in young children 2008 · CAF-5 · Healthy boys and girls, described as young children; age range not specified | 5 mg/kg | 1 day | — |
| Postprandial Metabolic Mesponses to High-fat Feeding in Healthy Adults Following Ingestion of Oolong Tea-Derived Polymerized Polyphenols: A Randomized, Double-blinded, Placebo-controlled Crossover Study 2023 · 100 mg PP plus 50 mg caffeine and 63 mg catechins (PP + CC) · Healthy adults; mean age 26 years (SD 7), 16 women; BMI mean 24.0 kg/m² (SD 2.7) | 50 mg | 1 day | — |
| Effects of Acute Caffeine Intake on Insulin-Like Growth Factor-1 Responses to Total Sleep Deprivation: Interactions with COMT Polymorphism - A Randomized, Crossover Study 2023 · caffeine condition · 37 healthy participants; age and sex not stated | 5 mg/kg | 1 day | — |
| Thermoregulatory responses to exercise in the heat: chronic caffeine intake has no effect 2006 · G3 · Active college-aged males (mean age 21.6 years) | 3 mg/kg | 6 days | — |
| Thermoregulatory responses to exercise in the heat: chronic caffeine intake has no effect 2006 · G6 · Active college-aged males (mean age 21.6 years) | 6 mg/kg | 6 days | — |
| Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels 2005 · C300 week (300 mg/day maintenance, caffeine challenge) · Healthy, nonobese adults; men and women; ages not specified; no diagnosed condition stated | 1.05 g | 7 days | 98 |
| Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels 2005 · C600 week (600 mg/day maintenance, caffeine challenge) · Healthy, nonobese adults; men and women; ages not specified; no diagnosed condition stated | 1.35 g | 7 days | 98 |
| Acute Dose-Response Effectiveness of Combined Catechins and Chlorogenic Acids on Postprandial Glycemic Responses in Healthy Men: Results from Two Randomized Studies 2023 · Dose A · Healthy men aged 41 ± 9 years, with normal blood glucose, Study 1 | 113 mg | 1 day | 18 |
| Acute Dose-Response Effectiveness of Combined Catechins and Chlorogenic Acids on Postprandial Glycemic Responses in Healthy Men: Results from Two Randomized Studies 2023 · Dose B · Healthy men aged 41 ± 9 years, with normal blood glucose, Study 1 | 113 mg | 1 day | 18 |
| Acute oral intake of a higenamine-based dietary supplement increases circulating free fatty acids and energy expenditure in human subjects 2013 · Supplement condition · Healthy, exercise-trained men and women; 16 participants, ages 22–29; no cardiovascular or metabolic disease | 270 mg | 1 day | 16 |
| Acute Dose-Response Effectiveness of Combined Catechins and Chlorogenic Acids on Postprandial Glycemic Responses in Healthy Men: Results from Two Randomized Studies 2023 · Dose C · Healthy men aged 47 ± 11 years, with fasting glucose 95–125 mg/dL, Study 2 | 99 mg | 1 day | 16 |
| Acute Dose-Response Effectiveness of Combined Catechins and Chlorogenic Acids on Postprandial Glycemic Responses in Healthy Men: Results from Two Randomized Studies 2023 · Dose D · Healthy men aged 47 ± 11 years, with fasting glucose 95–125 mg/dL, Study 2 | 99 mg | 1 day | 16 |
| Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial 2004 · DSEC (Metabolife 356) · Healthy adults, mean age 26.7 years; 40% women | 40 mg | 1 day | 15 |
| The Effects of Supplementation with p-Synephrine Alone and in Combination with Caffeine on Metabolic, Lipolytic, and Cardiovascular Responses during Resistance Exercise 2016 · p-synephrine + caffeine (SCF) · Healthy men; age not reported | 100 mg | 1 day | 12 |
| Effects of Ingesting Both Catechins and Chlorogenic Acids on Glucose, Incretin, and Insulin Sensitivity in Healthy Men: A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial 2022 · GTC+CCA-enriched beverage · Healthy men aged 20–60 years | 119 mg | 3 weeks | 11 |
| Caffeine counteracts the ergogenic action of muscle creatine loading 1996 · Cr+C · healthy male volunteers | 5 mg/kg | 6 days | 9 |
| Caffeine during exercise in the heat: thermoregulation and fluid-electrolyte balance 2009 · C(AFF) + CES · Seven endurance-trained, heat-acclimated cyclists; age and sex not reported | 6 mg | 1 day | 7 |
| Caffeine metabolism and epinephrine responses during exercise in users and nonusers 1993 · Users, caffeine exercise trial after caffeine or placebo ingestion period · Caffeine users; age, sex, and other health conditions not stated | 5 mg/kg | 7 days | 7 |
| The effect of beta-adrenergic and peroxisome proliferator-activated receptor-gamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue 2007 · ephedrine HCl plus caffeine/placebo (ECP) · Nondiabetic adult women and men; age range not reported | 600 mg | 16 weeks | — |
| The effect of beta-adrenergic and peroxisome proliferator-activated receptor-gamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue 2007 · ephedrine plus caffeine/pioglitazone (ECPio) · Nondiabetic adult women and men; age range not reported | 600 mg | 16 weeks | — |
| Coffee Consumption Increases the Antioxidant Capacity of Plasma and Has No Effect on the Lipid Profile or Vascular Function in Healthy Adults in a Randomized Controlled Trial 2016 · Medium-CGA coffee group (MCCGA) · Healthy men and women; mean age 38.5 years | 193 mg | 8 weeks | — |
| Coffee Consumption Increases the Antioxidant Capacity of Plasma and Has No Effect on the Lipid Profile or Vascular Function in Healthy Adults in a Randomized Controlled Trial 2016 · High-CGA coffee group (HCCGA) · Healthy men and women; mean age 38.5 years | 193 mg | 8 weeks | — |
| The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet 1994 · ephedrine plus caffeine (EC) · Obese women | 600 mg | 8 weeks | — |
| A Combination of Amino Acids and Caffeine Enhances Sprint Running Capacity in a Hot, Hypoxic Environment 2016 · caffeine + placebo · Subelite male team sport athletes | 3 mg/kg | 1 day | 8 |
| Caffeine attenuates vasovagal reactions in female first-time blood donors 1999 · 125 mg caffeine · female undergraduate first-time blood donors | 125 mg | 1 day | — |
| Effects of catechin enriched green tea on body composition 2010 · two servings of control drink (C) · Moderately overweight Chinese subjects; age and sex not specified | 10 mg | 90 days | — |
| The use of caffeine versus prophylactic naps in sustained performance 1995 · single-dose caffeine condition · young adult males without a stated condition | 400 mg | 2 days | — |
| The use of caffeine versus prophylactic naps in sustained performance 1995 · repeated 150-mg caffeine condition · young adult males without a stated condition | 600 mg | 2 days | — |
| The use of caffeine versus prophylactic naps in sustained performance 1995 · repeated 300-mg caffeine condition · young adult males without a stated condition | 1.2 g | 2 days | — |
| Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture 1993 · caffeine · obese patients receiving a 4.2 MJ/day diet | 600 mg | 24 weeks | — |